A comparative study of the in vitro antiproliferative activity of the extracts from the different developmental stages of pleurotus tuber-regium. by Wong, Sze Man. & Chinese University of Hong Kong Graduate School. Division of Biology.
A Comparative Study of the In vitro Antiproliferative 
Activity of the Extracts from the Different Developmental 
Stages of Pleurotus tuber-regium 
WONG Sze Man 
A Thesis Submitted in Partial Fulfillment 
of the Requirements for the Degree of 
Master of Philosophy 
in 
Biology 
©The Chinese University of Hong Kong 
September 2006 
The Chinese University of Hong Kong holds the copyright of the thesis. Any person(s) 
intending to use a part or whole of the materials in the thesis in a proposed publication 
must seek copyright release from the Dean of the Graduate School. 
|( 1 I OCT a ^ l l 
UNIVERSITY"""/MJJ 
\|^ IBRARY SYSTEM/^ / 
, " “ 
Thesis/Assessment Committee 
Professor Peter Chi-Keung Cheung (Chair) 
Professor Ming-Chiu Fung (Thesis Supervisor) 
Professor Yum-Shing Wong (Committee Member) 
Professor Jennifer Man-Fan Wan (External Examiner) 
xviii 
Thesis Committee i 
Acknowledgement ii 
Abstract (English Version) iii 
Abstract (Chinese Version) v 
Content Page vi 
List of Tables x 
List of Figures xii 
Abbreviations xvii 
Thesis Committee 
Prof. Peter Chi-Keung Cheung 
Prof. Ming-Chiu Fung 
Prof. Yum-Shing Wong 
Prof. Jennifer Man-Fan Wan (External Examiner) 
xviii 
Acknowledgement 
I would like to express overwhelming gratitude to my supervisor, Prof. Peter 
Chi-Keung Cheung, for his guidance and valuable advice to this project. It is my 
honor to have Prof. Ming-Chiu Fung and Prof. Yum-Shing Wong to be my thesis 
committee. I would like to give special thanks to Prof Fung for his advice in data 
analysis and Prof. Wong for kindly providing the Hs68 cell line. 
I am deeply appreciative of Mr. Ka-kei Wong for sharing his data to make 
this project successful. 
I am grateful to Dr. Mei Zhang and Miss Connie Kin-Ming Lai for sharing 
their experience and providing me much information in doing the in vitro 
antiproliferation assays. 
I would also like to offer my heartfelt thanks to Miss Elaine Wong and Miss 
Lim for assisting me in the flow cytometric analysis. Besides, my project could not 
be finished smoothly without the technical support of our lab technician, Mr C.C. Li. 
Last but not least, I am obliged for the support and encouragement from my 




The chemical compositions and in vitro antiproliferative activities of the 
water extracts from the fruiting body (coded as HWEl, HWE2 and HWE3 for three 
consecutive hot-water extraction, respectively), mycelium (EDP) and culture 
medium (CEP) of a novel edible mushroom Pleuwtus tuber-regium (PTR) were 
analyzed and compared. CEP and EDP were high in carbohydrate content (83.4% 
and 87.2o/o, respectively) and low in protein content (15.9% and 3.24%, respectively). 
Meanwhile, the three HWEs had comparatively higher protein content (>30.4%). 
HWEs having molecular weight above 156 x were rich in glucose (49.2-60.5%) 
and had substantial amount of mannose (20.4-26.9%) and galactose (14.8-16.3%)， 
speculating that they were heteropolysaccharide-protein complexes. As previously 
reported, EDP was rich in glucose (87.3%) with a moderate MW of 50.9 x lO. while 
CEP was mannan-rich (76.0%) with a low MW of 4.4 x 10^ suggesting they were 
probably glucan and mannan, respectively. 
The inhibitions on in vitro growth and proliferation of human acute 
promyelocytic (HL-60) and chronic myelogenous leukemia cells (K562) retarded by 
PTR extracts (concentration ranging from 12.5 |xg/ml to 400 |ig/ml) were more 
significant (p<0.05) than those of human breast cancer (MCF-7) and hepatocellular 
carcinoma (HepG2). No significant inhibition on normal monkey kidney (Vero) and 
human foreskin (Hs68) cells was found, suggesting that the antiproliferative activity 
of the PTR extracts was tumor-selective. HWE2 (approximate LC50 value: 25 |xg/ml) 
possessed the strongest growth inhibition on HL-60 cells whereas CEP (approximate 
IC50 value: 150 jxg/ml) had the most potent antiproliferative effect on HL-60 cells. 
Strong cytotoxicity against K562 cells was demonstrated by HWE2 and CEP (both 
having an approximate LC50 value of 25 |ig/ml) while HWE3 (approximate IC50 
value: 100 |xg/ml) reduced the % of proliferating K562 cells most significantly 
(p<0.05). 
All PTR extracts induced apoptosis in HL-60 cells with an increase of 
Bax/Bcl-2 ratio. However, apoptosis was not readily induced by CEP and HWE3 in 
K562 cells and resistance to apoptosis might have occurred after HWE2 and EDP 
treatments. Analysis from flow cytometry and western blot demonstrated that EDP 
caused G2/M arrest at 24 hours by lowering the Cdkl expression of HL-60 cells and 
xviii 
HWE2 caused S arrest which might be correlated with a depletion of Cdk2 and the 
increase of cyclin E expression in HL-60 cells. Therefore, PTR extracts isolated from 
different developmental stages of the mushroom have different chemical 
compositions which may influence their in vitro antiproliferative efficacies and 


















以g/ml)具有最大的生長抑制作用，而CEP (其IG�値均約爲150 figlml)則對 
HL-60細胞具有最大抗增生作用�HWE2和CEP對K562細胞具有很強的細胞 
毒性（LGd値約爲25 n g/ml)�HWE3則明顯能減少增生中的K562細胞百分 
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Chapter 1 INTRODUCTION 
1.1 Cancer treatment and potential novel antitumor agents 
It has been generally approved that surgery, radiotherapy and chemotherapy 
are the major treatments of cancer. However, a series of side effects was found on the 
patients who are subjected to these treatments, such as increasing the mortality and 
morbidity, lowering appetite, destroying the immune system. This is because they are 
not only toxic to cancer cells but also to normal cells and tissues as well (Boivin, 
1990). Innovation of other non-invasive treatments is essential to alleviate the 
suffering of cancer patients. 
An understanding of the occurrence of cancer helps to develop effective 
antitumor agents. As cancer originates from normal cell, the action of antitumor 
agents must be tumor-selective in order that no harmful effects act on normal cells 
but effectively eliminate the tumor ones (Mizuno, 1999). Due to the impaired 
proliferation and death machinery, tumor cells are unable to stop dividing or undergo 
" death process (Schwartz & Shah, 2005). Therefore, developing a compound which 
could restore the balance between cell growth and cell death by controlling the cell 
cycle progression and/or inducing apoptosis might become a novel agent in cancer 
treatment. 
1.2 History of mushroom polysaccharides in medical uses 
Mushrooms have been used in traditional oriental medical treatments for 
• 1 
many years. The medicinal effects of mushrooms have been documented in the 
Chinese and Japanese medical books, such as 'Sen Nong Ben Cao Jing and 'Ben Cao 
Gang Mu' in China and ‘Nihon Shoki，in Japan (Mizimo et al, 1995). Ganoderma 
lucidum, Coriolus versicolor, Lentinus edodes, Grifola frondosa are some of the 
examples of medicinal mushrooms employed since ancient times (Mizuno et al., 
1995; Ooi, 2000). They were reported to have various health-beneficial properties. G. 
lucidum and C. versicolor were described to promote longevity and good health 
while L edodes was used for treatment of cold. G. frondosa had the function of 
calming the nerve and the mind (Ooi, 2000). In the past, mushrooms were usually 
boiled in water and the hot water extracts were used as medicine. Mushroom 
polysaccharides were certainly one of these water-soluble components (Wassar, 
2002). In the 1960's, the medicinal effect of mushrooms and their corresponding 
bioactive components were demonstrated by scientific and medical studies (Mizuno, 
1995). The polysaccharides isolated from mushrooms have also been identified to be 
the most potent and active substance carrying the antitumor and immunomodulating 
properties (Wassar & Weis，1999; Wassar, 2002). Hence, mushroom polysaccharides 
have drawn much attention in cancer therapy since then. 
w 
Numerous mushrooms, particularly those belong to the class Basidiomycetes 
and Ascomycetes, have been proved to consist of antitumor polysaccharides derived 
from different developmental stages，including the fruiting bodies, sclerotia, mycelia 
and its culture filtrates (Ooi and Liu, 2000). Nowadays, some of the mushroom 
polysaccharides are validated to be used as nutraceuticals and even as medicine in 
Japan, China, Russia, U.S. and Canada (Mizimo, 1999; Wassar, 1999; Smith et a/.， 
2003). The most famous ones are lentinan extracted from the fruiting body of 
Lentinus edodes; schizophyllan obtained from the culture medium of Schizophyllum 
2 
commune; and PSK isolated from the mycelium of Coriolus versicolor (Mizuno, 
1996; Miles & Chang, 1997; Wassar, 1999). 
1.3 Life cycle of mushroom 
Mushrooms refer to marcofungi consisting of a mycelial network and a large 
enough distinctive fruiting body which can be seen by naked eyes. They usually 
belong to the Class Basidiomycetes and some are Ascomycetes (Ooi & Liu, 2000). In 
the class Basidiomycetes, ‘club-like，spores called basidia are produced in the cap of 
fruiting body. Germination of the spores gives hyphae that extend at the tip and form 
a primary mycelium. At the same time, secondary mycelium is formed from hypha 
produced by fusion of two compatible hyphae. Some of the hyphae would grow at 
some other regions leading to branching. A bunch of hyphae and mycelia are fused 
together to form a mycelial network. The network becomes larger and larger and 
finally a new macroscopic fruiting body is germinated. New spores would then be 
produced by the mature fruiting body and dispersed to begin a new life cycle (Fig. 
1.1) (Stamets, 1983; Wassar & Weis, 1999; Chang & Miles，2004). 
� A special morphological form, sclerotia, could be developed under stressful 
conditions, for example, starvation, unfavorable humidity or temperature for 
germination. The most common sclerotium is from Poria cocos (also called ‘Fuling’ 
in China) that is widely used in Chinese soups. It is a compact mass of mycelia and 
its thickened wall and the nutrient- and chemical-rich inner part allow it to overcome 
the undesirable situations and even survive for many years (Hoffman, 1999). When 
the conditions become favorable, sclerotia may form fruiting bodies (Fig. 1.2), 
producing and dispersing spores, continuing the life cycle (Carlile et al,, 2001). 
3 
声 \ 1 
J L 
^ ^ 厂 此"、、、、秦 
nruiitbody 
Development 
^ Fig. 1.1 The typical life cycle of mushroom including the stages of mycelial 
^ hypha, sclerotium and fruiting body (Stamets, 2000). 
Fig. 1.2 A fruiting body on the top of a sclerotium of Pleurotus tuber-regium (PTR). 
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1.4 Classification of antitumor mushroom polysaccharides 
Polysaccharides are macromolecules which are made up of numerous 
monosaccharides interconnecting together by glycosidic linkages. They may be 
linear or highly branched as one monosaccharide can join to more than two other 
monosaccharides (Daba & Ezeronye, 2003). Owing to this, several terms have been 
derived from the structure of polysaccharides such as glucans and glycans. Glucan is 
a polysaccharide that consists of glucose only, and only glucose is yielded by acid 
hydrolysis (Mizuno, 1999; Daba & Ezeronye, 2003). Glycan means the 
polysaccharide that consists of monosaccharides other than glucose (Daba & 
Ezeronye, 2003). 
Cell wall of mushroom is mainly made up of protein, chitin and 
polysaccharide such as glucans and mannans (Wu et al.’ 2004). By applying different 
extraction methods, various antitumor polysaccharides originating from the cell wall 
can be obtained. These polysaccharides could be divided into three major groups 
according to the monosaccharide constituents: p-glucans, heteropolysaccharides and 
polysaccharide-protein complexes (Mizuno, 1999). 
1.4.1 p-glucans 
Antitumor polysaccharides of mushroom are mostly p-glucans. In particular, 
they are commonly (1—3)- |3-D-glucopyranans with (l->6)- p-D-glucosyl branches, 
having an average molecular weight of 5 xlO^ and 20 xlO^ (Mizuno et al” 1989). 
These P-D-glucans are oriented in a right triple helical form as indicated by NMR 
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analysis and x-ray diffraction (Marchessault et al.’ 1977). 
P-glucans are existed in the forms of triple helix, single helix or random coil. 
They could exist as different conformations in different states (solid or liquid state) 
resulted from different preparations. Aqueous-soluble branched (1—3)- p-glucans are 
single-helix by coordinating with water molecules (Ohno, 2005), but mostly, in 
triple-helical structure (Mizuno et al., 1995). They form a gel or even agar-like 
structure during prolonged storage because of their intermolecular interaction (Ohno, 
2005). Low-molecular linear (1 — 3)- P-glucans are readily soluble in aqueous 
solution and are maintained in random coil (Yadomae and Ohno, 1996). However, 
those having high molecular weight are not soluble in aqueous solution, and could 
form gel due to their long chain length whereas those having intermediate chain 
length form precipitate (Mizuno et al, 1995). On the other hand, the gel formed by 
linear and branched (1 — 3)- p-glucans are in single helix and triple helix 
conformations (Mizuno et al., 1995). Their solubilities could be improved under 
alkaline condition or in DMSO solution because of the conversion of their helical 
conformations to random coil. The original secondary structure could be resumed 
" back to either single helix or triple helix after adding HCl for neutralization (Mizuno 
et al, 1995). However, recovery of the helical conformation was not achievable in 
some cases, such as schizophyllan, even after neutralization of the alkali treatment 
(Hobbs, 2005). 
For instance, lentinan and schizophylllan, isolated from Lentinus edodes and 
Schizophyllan commue, having a high molecular weight of 5x10^ and 4.5x10^ 
respectively, have been revealed to have a main chain of (1—>3)-P-D-glucan with 
(l->6)-linked branch at an interval of three main chain units (Mizuno et al” 1995). 
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Other antitumor polysaccharides isolated from the fruiting bodies of Ganoderma 
lucidum, Coriolus versicolor, Poria cocos and Grifola frondosa are also (3-glucans 
(Mizuno et al, 1995). 
1.4.2 Heteropolysaccharides 
Apart from f-glucans，heteropolysaccharides have also been reported to have 
antitumor activities. Glucuronic acid, galactose，mannose, arabinose or xylose, or the 
combinations of them, is usually the main monosaccharide in the side chain of a (3-
glucan main chain (Mizuno et al, 1995). In heteroglycans，side chains usually 
contain arabinose, mannose, fucose, galactose, xylose, glucuronic acid and glucose 
or different combinations of them (Wassar, 2002). A large number of the 
heteropolysaccharides have been shown to be effective against tumors (Ooi and Liu, 
1999), for example, antitumor glucomannan isolated from the mycelia of Agaricus 
blazei (Tsuchida et al, 2001). Several heteroglycans have been extracted from the 
fruiting bodies of Ganoderma lucidum (Wassar and Weis, 1999). Also, exocellular 
^ heteropolysaccharides (glucuronoxylomannan) have been obtained from Tremella 
�� mesenterica (Vinogradov et al., 2004). 
1.4.3 Polysaccharide-protein complexes 
Besides the above two classes, polysaccharides with bound protein is the 
third class of antitumor mushroom polysaccharides which is called polysaccharide-
protein complex or protein bound polysaccharides. PSK and PSP derived from the 
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mycelia of Coriolus versicolor (Tsukagoshi et al, 1984) are the polysaccharide-
protein complexes being most extensive studied. PSK which was a product of Japan 
was isolated from the strain CMlOl of C. versicolor whereas PSP was produced in 
China, isolated from the strain COV-1 (Ng, 1998). They are branched (1—3)-p-, 
(1—4)-a-glucans and are rich in aspartic acid and glutamic acid in their polypeptide 
moieties (Ng, 1998; Lau et al, 2004). PSP consists of mainly arabinose, rhamnose, 
galactose, mannose and xylose while the polysaccharides of PSK has fucose, 
galactose, mannose and xylose in their side chains (Cui and Chisti, 2003). They 
showed in vitro direct cytotoxicity on numerous tumor cell lines including leukemia 
(HL-60)，lymphoma, (Lau et al, 2004), hepatoma (HepG2) (Dong et a/., 1996) and 
breast cancers (MCF-7) (Dong et a/.，1997). Moreover, PSP exerted strong 
immunomodulatory activities by increasing the level of y-interferon, interleukin-lp,-
2 and -6 and the proliferation of T-cells (Ng, 1998; Hsieh et al, 2002). These 
cytokines and T-cells are responsible for the enhancement of the immune system. 
1.5 Structure-activity relationship of mushroom polysaccharides 
M 
�� Polysaccharides can be made up of different monosaccharides together with 
other components like proteins and they have different linkages, branching and 
conformations and hence different molecular mass and water solubility. The potency 
of antitumor activity of mushroom polysaccharides varies, but it has been suggested 
that it is associated with their own structural characteristics, including molecular 
mass, degree of branching and substitution, conformation, presence of bound protein, 
chemical modification and water solubility (Kiho et al,’ 1989; Adachi et al” 1990; 
Chihara, 1992; Mischnick, 1995; Ohno et al, 1995; Wassar, 2002; Surenjav et al., 
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2006). 
1.5.1 Lentinan as typical example 
It is generally suggested that antitumor mushroom polysaccharides rely on 
the basic structure of a triple-helical (1—6) branched (1—3)-|3-D-glucan with high 
molecular mass (Wassar, 2002). A recent research analyzing the structural effects of 
(l-^3)-P- D-glucans from Lentinus edodes is a good example to illustrate this point 
(Surenjav et al, 2006). Two triple helical and protein bound (1—>-3)-p-D-glucans (L-
I2 and L-I3) with molecular weights 1.57 x 10^  and 1.51 x 10^ respectively were 
isolated from two different strains of fruiting bodies of Lentinus edodes. Several 
derivatives were produced including their deproteinized fractions (LNP-I2 and LNP-
I3)，fractions with lower molecular weight (LU-I2 and LU-I3) and those with single 
flexible chain (LSC-I2 and LSC-I3) which were produced by dissolving the native 
fractions in DMSO solvent which can break the intra- and intermolecular hydrogen 
bonds. They had significant inhibitory effects on the growth of Sarcoma 180 (S-180) 
solid tumor in Kunming mice (Surenjav et al, 2006). L-I2 and L-I3 inhibited S-180 
tiimor with a range of inhibition % from 25.9 to 70.0 at a daily dose of 20 to 60 mg 
per kg body weight of the mice. However, LNP-I2 and LNP-I3 could only have a 
tumor inhibition % about 40. LU-I2 and LU-I3 also exhibited a growth inhibition on 
S-180 tumor smaller than 30% in Kunming mice. Besides, the inhibitory effects of 
LSC-I2 and LSC-I3 were sharply decreased, ranging from only 0.6% to 16.7%. All 
these results suggested that bound protein content, high molecular weight and triple 
helix of the polysaccharides are important structural parameters for the antitumor 
potency of polysaccharides (Surenjav et al, 2006). 
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1.5.2 Molecular weight 
Polysaccharides having molecular weight higher than 2 xlO^ are suggested to 
have more potent antitumor activity (Bohn and BeMiller, 1995). Two water-soluble 
heteropolysaccharides which isolated from Poria cocos by 0.9% sodium chloride and 
then hot water, with high molecular weight of 2.6 xlO^ and 8.9 xlO^ respectively 
demonstrated significant in vivo and in vitro antitumor activities (Jin e/ al, 2003). 
They inhibited the growth of S-180 tumor by 56.0% and 66.8% in BALB/c mice， 
respectively. Also, their significant cytotoxicities against HL-60 leukemic cells and 
HepG2 liver cancer cells were observed (Jin e/ al, 2003). It is noteworthy that these 
heteropolysaccharides are mainly consisted of a-D-glucose, mannose and galactose 
(Jin et al, 2003)，implying that polysaccharides other than P-glucans could give 
promising antitumor activities as well. 
In spite of this, polysaccharides with low molecular weight also demonstrated 
significant antitumor activities. A water-soluble a-glucan isolated from the mycelia 
of Pleurotus ostreatus had molecular weight smaller than IxlO^ exerting significant 
- inhibitory effect of 93.75% on HT-29 colon cancer cells by apoptotic induction via 
“ upregulating the expression of pro-apoptotic Bax and cytochrome c (Lavi et al., 
2006). It indicated that not only p-glucans with high molecular weight, but also low-
molecular-weight a-glucan could show significant antiproliferative activity. 
1.5.3 Conformation 
Besides, not all the polysaccharides with high molecular could enhance the 
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antitumor activities. The in vivo and in vitro antitumor activities of the fractions 
derived from Lentinan by different degree of ultrasonication were highly affected by 
their molecular weight and also the conformation (Zhang et al.’ 2005). The triple 
helical fractions having moderate molecular weight of 14.9 xlO"^  and 18.4x10'^  
exerted the highest inhibition ratios on the growth of S-180 solid tumor in BALB/c 
mice at a high dose of 60 mg/kg and a low dose of 20 mg/kg, respectively. However， 
the tumor inhibitory effects was decreased substantially (to 16.8%) after their 
conformations were changed to single flexible coil (Table 1.1). In contrast，the 
fraction with lower molecular weight exhibited the strongest %' inhibition towards S-
180 cells in vitro. Therefore, triple-helical polysaccharides having moderate and low 
molecular weight had the strongest in vivo and in vitro antitumor effects among the 
fractions derived from Lentinan. 
1.5.4 Chemical modification 
Chemical modification also enhances the water solubility of the 
polysaccharides and their antitumor activities. Carboxymethylation, 
s. formylmethylation, aminethylation and sulfation can introduce an ionic group to the 
polysaccharides so as to improve their water solubility (Ooi and Liu, 2000). The 
polysaccharides that are relatively water-soluble usually have stronger antitumor 
activities. Huang et al, (2006) demonstrated that sulfation could enhance the 
antitumor activities to a-glucans isolated from Poria cocos mycelia. Six water-
soluble sulfated a-glucans with various molecular weights were modified from the 
native water-insoluble a-glucans extracted from Poria cocos mycelia by introducing 
the hydrophilic sulfogroups on the backbone of glucan. The antitumor activities of 
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these fractions were tested against Sarcoma 180 tumor cells in BALB/c mice in vivo. 
The inhibition ratio of native fraction was 7.41% while that of the six sulfated 
derivatives was ranged from 32.2% to 52.0%, showing that all the sulfated fractions 
were effective in suppressing the SI80 tumor cell growth (Huang et al, 2006). In 
vitro antitumor activities of the native and sulfated fractions at three concentrations 
(0.005, 0.05 and 0.5 mg/ml) were also investigated with the help of HepG2 and 
Sarcoma 180 cells. The native fraction could not inhibit both cell lines; however, all 
the sulfated derivatives inhibited the growth of two cell lines significantly with an 
inhibition ratio of 50% (Huang et al, 2006). It therefore indicated sulfation can 
enhance both in vivo and in vitro antitumor activities of mycelial a-glucans extracted 
from Poria cocos. 
Furthermore, a water-insoluble (1^3)-p-glucan isolated from the scleroria of 
Poria cocos was chemically modified by sulfation, carboxymethylation, methylation, 
hydroxyethylation and hydroxypropylation to produce five water-soluble fractions 
with molecular weight of 3.8xl0\ 18.9xl0\ 16.0xlo4, 76.8x10^ and 224.3 
respectively (Wang et al, 2004). The resulted sulfated, carboxymethylated and 
methylated fractions were highly soluble in water. Their in vitro antiproliferative 
activities against MKN-45 and SGC-7901 gastric cancer cells showed a dose-
dependent manner (0.5 mg/ml, 1 mg/ml and 2 mg/ml). These three modified 
fractions exhibited a 30% higher inhibition ratio at 2 mg/ml than that of the native 
fractions and other chemically modified ones (Wang et al.’ 2004). Also, the in vivo 
antitumor activity of all the chemically modified fractions against S-180 solid tumor 
in BALB/c mice was higher than the native fractions, among which the sulfated, 
carboxymethylated and methylated fractions showed a ten-fold stronger inhibition 
than the native one. It is believed that the higher the water solubility the 
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polysaccharides had, the stronger the antitumor activity they could exert. Therefore, 
chemical modification might enhance the antitumor activity together with a moderate 
molecular weight of polysaccharides. 
1.5.5 Degree of branching 
Degree of branching is also a determining factor for the antitumor property of 
polysaccharides. Polysaccharides with high molecular weight (1x10^-2x10^) and 
with the degree of branching between 0.20 and 0.33 were observed to have most 
remarkable antitumor activities (Bohn and BeMiller, 1995). Lentinan and 
schizophyllan have an average degree of branching of 0.33 (Bohn and BeMiller, 
1995). For those with degree of branching smaller than 0.25, they also showed 
strong activities if they had no ordered structure and their molecular weights were 
lower than 2x1 O^  (Bohn and BeMiller, 1995). In some cases, antitumor activities of 
polysaccharides could be enhanced after debranching. This was illustrated by 
Pachyman and its debranched derivative named Pachymaran (Chihara et al, 1970). 
, Pachyman is a P-glucan with (1—6) P- branches obtained from the sclerotia of Poria 
cocos with no antitumor activity. After debranching by Smith degradation, 
Pachymaran was formed as a straight chain P-glucan with potent antitumor activity 
(Chihara et al, 1970). 
From the above, it could be realized that the relationship between degree of 
branching and antitumor activity of polysaccharides is very complicated. In summary, 
moderate branching was essential for the polysaccharides with high molecular 
weight (Ohno, 2005) and low degree of branching might favorable for those with 
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lower molecular weight. However, antitumor activities sometimes could only be 
obtained from those without branch chain. 
The structure-activity relationship of mushroom polysaccharides is still 
controversial as shown by many contradictory results. It was due to the huge 
variability in the chemical structure of antitumor polysaccharides and difficulties in 
the identification of the bio-active components (Table 1.2). For instance, although the 
most well-known antitumor mushroom polysaccharides, Lentinan and Schizophyllan 
are p-(l—3)-glucans，antitumor polysaccharides with other structures such as those 
mentioned above, a-glucans isolated from culture filtrates of Pleurotus ostreatus 
(Lavi et al, 2006) and sulfated a-glucans isolated from Poria cocos mycelia (Huang 
et al, 2006), undoubtedly also had prominent in vitro antitumor activities. Thus，this 
diversity makes the confirmation of the structure-activity relationship of 
























































































































































































































































































































































































Table 1.2 Examples of antitumor mushroom polysaccharides isolated from different 
developmental stages * 
Mushroom Fruiting body Mycelium Culture medium 
Agaricus p-glucan, Glucomannan-protein Mannan-protein 
blazei Insoluble P-glucan, 
Hetero-P-glucan 
Coriolus p-glucan p-glucan (PSP, PSK) -
versicolor 
Ganoderma p-glucan, - p-glucan 
lucidum Hetero-P-glucan 
Grifola Grifolan (p-glucan), Mannogalatofucan, -





Lentinus p-glucan a-Mannan-peptide Hetero-glucan 
edodes protein 
No polysaccharides were recorded 
* Adapted from Mizuno et al., (1995); Wassar and Weis, (1999) 
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1.6 Antitumor mushroom polysaccharides obtained from different 
developmental stages 
As mentioned in 1.3, mushroom can exist in different morphological forms 
during the life cycle. Polysaccharides extracted from the different stages of the same 
mushroom have not only different chemical characteristics and also different 
antitumor potency. 
It could be observed that the number of polysaccharides isolated from the 
fruiting body of mushroom was more than those from mycelium and culture medium. 
Twenty-nine, six and one polysaccharides were successful isolated from the fruiting 
body, mycelium and culture medium of Ganoderma tsugae (Wasser, 2002). This 
phenomenon was also commonly found in other mushroom such as Grifola frondosa, 
Ganoderma lucidum and Pleurotus ostreatus (Table 1.2) (Mizuno et al” 1995; Wassar 
and Weis, 1999). � 
Ganoderma tsugae is a mushroom having fruiting bodies，mycelia and culture 
medium from which polysaccharides have been isolated and investigated. From its 
fruiting body, 14 water-soluble polysaccharides belonged to protein-containing 
glucogalactans with mannose and fucose, and 15 water-insoluble protein-containing 
(1—3)-p-glucans with different proportions of protein were successfully isolated, 
among which seven glycans exhibited strong antitumor acitivities (Wang et al, 1993). 
Six water-soluble polysaccharides having different structural characteristics 
were extracted from the mycelium of G. tsugae (Peng et al, 2005), including 
heterpolysaccharide-protein complexes, p-D-glucans, polysaccharides with both 
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(1—3)-p-D-glucans and (1—4)- a-D-glucans, and (1—6)branched (l->3) -p-D-
glucans, as revealed by ^^CNMR and IR spectra. Their molecular weights were 
ranged from 62.8 xlO"^  to 468 xio^ The fractions which were found to be 
heterpolysaccharide-protein complexes and mixtures of (1—3) -P-D-glucans and 
(1—4)- a-D-glucans possessed significant potent antitumor activity (>50% inhibition 
ratio) against the Sacroma 180 in vivo. It was suggested that the antitumor activity 
might be associated with the protein and galactose content as well as the lower 
molecular weight of the heteropolysaccharide-protein complexes (Peng et al, 2005). 
Besides, a crude extracellular polysaccharide and its two fractionated 
derivatives were obtained in the culture filtrate of G. tsugae (Peng et al, 2003). 
Although all three polysaccharides had similar monosaccharide composition, the two 
fractionated derivatives existed as compact coil chain and slightly expended coil 
chain, respectively. The molecular weight of all the two fractionated derivatives of 
extracellular polysaccharides (8.35 xlO"^  and 23.8 xlO"^ ) was much lower than the 
crude one (92.0 xlO"^ ). The crude extracellular polysaccharide showed a significantly 
higher in vivo tumor inhibition (60.44%) injected peritoneally at a daily dose of 5 mg 
争 
per kg body weight in response to Sacroma 180 solid tumor grown in BALB/c mice. 
This might be due to its high protein content (23.1%) which implied a protein-bound 
polysaccharide (Peng et al, 2003). 
Apart from the developmental stage, the mushroom antitumor 
polysaccharides isolated from the same stage but different strains might not be 
structurally identical. PSK isolated from the strain CMlOl and PSP from the strain 
COV-1 of Coriolus versicolor is a good example. They have the same proportion of 
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polysaccharide but with different protein moiety and different monosaccharide 
profile. PSK consisted of fucose whereas PSP had rhamnose and arabinose (Ng, 
1998). 
The chemical components used in the culture media of mycelium affect the 
mycelial polysaccharides produced. The water-soluble heteropolysaccharides 
extracted from a wild strain and a cultivated strain of Poria cocos mycelia cultured in 
two media containing bran extract and com steep liquor respectively were unique in 
their chemical compositions and molecular weights (Jin et al, 2003). Their in vivo 
antitumor activities against Sacroma 180 in BALB/c mice and in vitro growth 
inhibitory effect on HL-60 and HepG2 cell lines varied. The heteropolysaccharides 
isolated from the wild stain cultured in com steep liquor, containing more mannose 
and galactose and protein, showed stronger in vivo antitumor activities. Although 
from different strains, the heteropolysaccharides isolated from the mushroom 
cultured in com steep liquor inhibited the growth of HL-60 and HepG2 cells more 
significantly. 
Interestingly， structural characteristics of even the same type of 
V� 
polysaccharides obtained from the same strain of mushroom might be slightly 
different due to the different degree of maturity. Water-soluble glucans were 
extracted from the fruiting bodies of Agaricus hlazei {Agaricus hrasilensis) in 
different levels of maturity including those cap-closed immature with no spores, cap-
opened mature with immature spores and cap-opened with mature spores (Camelini 
et al., 2005). ^^ C NMR spectra showed that the polysaccharides isolated from all the 
mature stages contained (1^2)- /5 -glucans, (1—6)-/3-glucans，（1—3)-/3-glucans 
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and (1—6)- a - glucans. However, only cap-opened fruiting bodies contained (1—4)-
a -glucans, which was rather abundant in those with mature spores. Except (1—2)-
3 - glucans and (1-^4)- a -glucans, all mushroom polysaccharides obtained above 
were proven to have antitumor activities (Mizuno et al., 1990; Fujimiya et al.’ 1998). 
Moreover, the growth inhibitory effect of PSP (1 mg/ml)，which was isolated from 
the mycelium of Coriolus versicolor, on Molt 4 leukemic cells was increased with an 
increase in the cultivation time and the maturity of the mycelia (Lee et al” 2005). 
Thus, even in the same developmental stage，mushrooms with different maturity 
would have slightly differences in both their chemical characteristics and their 
antitumor efficacies. 
1.7 Mechanisms of in vitro antitumor activity of mushroom polysaccharides: 
cell cycle arrest and apoptotic induction 
Most of the mushroom polysaccharides are suggested to be biological 
response modifiers (BRM) (Wassar and Weis, 1999) of which actions are host-
mediated that via the immune response (Wassar, 2002). BRM is a substance inhibits 
the tumor without harming or adding extra stress on the host, but help the host to 
adapt various environmental and biological stresses so as to minimize the sufferings 
brought from the disease (Wassar and Weis, 1999). Immunomodulatory effect of 
mushroom polysaccharides has been accepted to be the mechanism of their antitumor 
activities that the polysaccharides activate the immune system of the host rather than 
direct killing the cancer cells (Wasser, 2002). However, in recent years, many 
mushroom polysaccharides have been suggested to have direct cytotoxicity towards 
various cancer cell lines and hence a new mechanistic approach has been aroused. 
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Cell-cycle arrest and apoptosis are recently used to study the mode of actions of 
cancer treatment since cancer cells, unlike normal ones, have uncontrolled 
proliferation and defective death machinery as mentioned earlier in 1.1. The 
mushroom polysaccharides were proposed to modify the regulation of cell cycle and 
the molecules involved in apoptosis. As a result, the cancer cells would stop further 
proliferation and undergo programmed cell death. 
1.7.1 Cell cycle regulation 
Defined by Howard and Pelc (1953), cell cycle involves DNA synthesizing S 
phase and mitotic M phase. These two phases are separated by Gapl (Gi) and Gap2 
(G2) (Fig 1.3). Most cells are non-dividing in human body and stay in a quiescent 
state classified as Go during which cellular growth still occurs (Schwartz & Shah, 
2005). When a cell is stimulated by growth factors, it must pass through Gi, S, G2 
and M phases sequentially to complete the cell division that produces two offsprings 
(Fig 1.3). The cell cycle is tightly regulated by cyclins, cyclin-dependent kinases 
, (Cdk), cyclin-dependent kinase inhibitors (Cdki) and tumor suppressor proteins 
�� (Sherr, 2000). Cyclins in each phase when associated with their corresponding cdks 
can activate them. The activated cyclin-cdk complexes in one phase drives the cell to 
pass to the next phase of cell cycle. Cyclin D/ Cdk4 or 6 complex is important in the 
progression of Gi phase. Cyclin E/Cdk2 is responsible for the Gi/S transition. Cyclin 
A/Cdk2 is necessary for S phase progression while cyclin A/Cdkl helps the cell to 
move through G2 phase. Cyclin B/Cdkl governs the occurrence of M phase (Baguley, 
2002; Schwartz & Shah, 2005). 
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P21 ~ ~ ~ ： M 
p27 Cyclin B (mitosis) p15 
S phase cease 
(DN/V synthesis)^^^!^^^ division 
P27 1 丨 
Fig 1.3 The key regulators in the cell cycle (adapted from Sherr, 2000; Schwartz & 
Shah, 2005) 
When the cell is activated in response to the growth factors, it enters the cell 
cycle in Gi phase and passes through the restriction point. Stimulation of growth 
factors leads to the induction of cyclin D production in mid- Gi phase. Cyclin D 
would bind to and activate Cdk4 and Cdk6 (Sherr, 1995). Cyclin D/Cdk4(6) complex, 
" together with cyclin E/Cdk2 complex, phosphorylates and inactivates tumor 
suppressor protein Rb so that E2F transcription factor would no longer be bound 
(Malumbres and Barbacid, 2001). This would result in the transcription of several 
essential proteins for S phase and the cell is ready to enter S phase (Sherr, 2000). In 
the Gi/S boundary, Cdk2 would bind to cyclin A and this complex is responsible for 
the progression of S phase where DNA replication is being performed. When the 
DNA synthesis is completed correctly, cyclin A would bind to Cdkl instead of Cdk2, 
facilitating the Gi phase progression. Cyclin B would be formed in late- G2 phase but 
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remains inactive in cytoplasm until mitosis begins. When the cell is ready for cell 
division, cyclinB/Cdkl complex is activated by phosphatase cdc25 and is relocated 
into the nucleus to drive the cell to M phase and undergo mitosis (Schwartz & Shah, 
2005). 
There are three cell cycle checkpoints located in Gi/S boundary, S phase and 
Gi which ensure the cell in the cell cycle completed the process of earlier stage 
without errors (Pommier et al., 2002). The Gi checkpoint is closely related to the 
tumor suppressor proteins p53 and pRb. They govern the pathways that 
downregulate the cyclin D/Cdk4(6) and cyclin E/Cdk2 complexes and cause Gi 
arrest in response to DNA damage. The p53 protein has been regarded as ‘the 
guardian of the genome' as it also involves in apoptotic pathway. When there is DNA 
damage, it can either stop the cell cycle in order to allow the repair of DNA or trigger 
apoptosis to kill the DNA-damaged cell (Eastman, 2004). 
S-phase checkpoint is also called the replication checkpoint that monitors the 
DNA synthesis and the cell progression during S phase (Schwartz & Shah, 2005). 
The mechanism of S-phase checkpoint pathway is not fully discovered, but it is 
thought to involve the inhibition of Cdk2 and further block the loading of CDC45 
onto DNA. As a result, DNA polymerase would not be recruited and so no DNA 
replication was initiated (Kastan and Bartek, 2004). On the other hand, when there is 
DNA damage occurred in G2 phase or those unrepaired DNA damage from previous 
S or Gi phase, G2 checkpoint would be initiated. It is also greatly dependent on p53 
pathway to suppress the activity of cyclin B/Cdkl complex in order to halt the cell 
(Kastan and Bartek, 2004). 
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Deregulation of the either one of the proteins involved in cell cycle leads to 
unlimited cell growth. For instance, p53 and pRb proteins are usually lost in human 
cancers and so repair mechanism cannot take place (Kastan and Bartek, 2004). 
Targeting these proteins in cell cycle and hence restore the cell cycle checkpoints are 
the possible new strategy in cancer treatment. 
1.7.2 Induction of apoptosis 
Apoptosis is a programmed cell death for removing the unwanted cells in 
which their contents would be absorbed by neighboring tissue, so no inflammatory 
response results (Baguley, 2002; Fesik, 2005). During apoptosis, a series of 
biochemical and morphological changes were occurred. Biochemically, it involves an 
extrinsic death receptors-dependent pathway and an intrinsic mitochondria-
dependent pathway (Fig 1.4). Both two pathways rely on caspases to transmit the 
signals in the cell and carry out the morphological changes of apoptosis (Cory and »  
„ Adams, 2002; Okada and Mak，2004). Due to a series of changes in biochemical 
�� pathway, it is typical to observe nuclear shrinkage and chromatin condensation in the 
early stage of apoptosis. DNA would become fragmented in the presence of DNA 
fragmentation factors. In late apoptosis, cell fragmentation, membrane blebbing, 
formation of apoptotic bodies which are finally engulfed by phagocytosis would be 
resulted (Igney and Krammar, 2002). 
Mitochondria is an integral part in the intrinsic pathway of apoptosis which is 
controlled by the Bcl-2 family proteins and other mitochondrial proteins such as 
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cytochrome c (Fig 1.4) (Lavi et al, 2006). Bcl-2 family proteins are key regulators in 
apoptosis that involve antiapoptotic and proapoptotic proteins. Bcl-2 family proteins 
are divided into three subfamilies according to their conserved Bcl-2 homology (BH) 
domains, including anti-apoptotic Bcl-2 family, pro-apoptotic Bax family and BH3-
only family (Cory and Adams, 2002). Anti-apoptotic Bcl-2 family consists of Bcl-2, 
Bcl-w and Bcl-xL that inhibit the induction of apoptosis by blocking the activation of 
pro-apoptotic Bax family proteins. Pro-apoptotic Bax family involves Bax, Bak and 
Bok which promote apoptosis by disrupting the mitochondrial membrane and lead to 
the release of cytochrome c. BH3-only family, such as Bid, Bim, Bad and Bik, 
functions like a DNA-damage sensor that can only promote apoptosis in the presence 
of Bax family proteins and help to inhibit the Bcl-2 family (Cory and Adams, 2002; 
Fesik, 2005). Among the Bcl-2 family proteins, antiapoptotic Bcl-2 and proapoptotic 
Bax are the most important and highly investigated regulatory proteins (Oltvai et 
a/., 1993). 
When DNA damage is detected, tumor suppressor protein p53 would be 
activated and its downstream product, Bax, translocates from the cytosol to the 
mitochondrial membrane, neutralizing the antiapoptotic Bcl-2 (Fig 1.4). The 
V-
inactivation of Bcl-2 protein was further inhibited by binding with BH3-only protein, 
such as Bid. As a result, the release of cytochrome c from the mitochondria was 
induced. Together with Apaf-1 and procaspase 9, apoptosome is formed. Finally, 
caspase 3 was activated and apoptosis results (Cory and Adam, 2002; Okada and 
Mak, 2004). 
The balance of antiapoptotic and proapoptotic proteins cannot be neglected. 
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Bax/Bcl-2 ratio is usually used to study the mechanism of apoptosis since it 
determines the susceptibility of cells to apoptosis and the therapeutic response to the 
chemotherapy (Raisova et al, 2001). However, apoptosis is counteracted if the level 
of Bcl-2 is too high (Oltvai et al., 1993), therefore, cells with higher Bax/Bcl-2 ratio 
is susceptible to apoptosis. 
In the extrinsic pathway, when there is death signal received by the cell 
surface bound death receptor, the death domain would recruit adaptor molecule, 
which further interact with two caspase 8 (Fig 1.4). The activation of caspase 8 
would further cleave and activate the downstream effector caspases，such as, caspase 
3，and finally apoptosis was initiated and a series of morphological changes would be 
observed (Cory and Adams, 2002; Okada and Mak, 2004). The two apoptotic 
pathways would be converged to produce an amplified action by cleaving the Bid by 
caspase 8. The cleaved Bid would bind to Bax and activate the intrinsic pathway as 
described above (Fesik, 2005). 
Vs 
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Fig 1.4 Simplified main apoptotic pathways: the extrinsic death receptors-dependent 
pathway (left) and the intrinsic mitochondria-dependent pathway (right) (adapted 
from Fesik, 2005; Igney and Krammar, 2002). 
, 1.8 The novel strategies for cancer treatment 
Unlike normal cells, cancer cells have uncontrolled growth and proliferation. 
Cancer cells strive for alive by disrupting the apoptotic pathway and deregulating the 
cell cycle (Fesik, 2005). Moreover, a lethal disease, metastasis, would be developed 
in the late stage of cancer. It refers to a group of cell detached from the original site 
and passed through the blood circulation to reach another site to initiate growth again. 
Finally, cancers are found in more than one organs (Gibbs, 2003). Thus, the recent 
27 
approach by balancing the growth and death of cancer cells can be done by 
controlling their cell cycle and promoting apoptosis. 
PSP derived from the mycelia of Coriolus versicolor, (Chow et al, 2003; Lau 
et a/.,2004; Yang et a/.,2005; Hui et al, 2005), protein-bound polysaccharides (PL) 
isolated from Phellinus linteus (Li et al., 2004) and p-glucan extracted from mycelia 
of Poria cocos (Zhang et al, 2006b) all have in vitro growth inhibitory effects 
resulted from arresting cell cycle or induction of apoptosis. In particular, PSP was 
being most extensively investigated. 
The polysaccharide-peptide (PSP) isolated from Coriolus versicolor inhibited 
the breast cancer cells (MDA-MB-231) upon 24 hour incubation and it was believed 
to be via apoptosis by upregulating the p21 expression and decrease cyclin D1 
expression (Chow et a/.,2003). An ethanol extract derived from G. versicolor 
inhibited the growth of human B-cell lymphoma Raji and promyelocytic leukemic 
HL-60 and NB-4 cell significantly, with the proliferation of HL-60 cells being 
suppressed the most (Lau et al, 2004). The antiproliferative activity of the ethanol 
’ extract was suggested that to be due to the induction of apoptosis as the induction of 
nucleosome production in a dose-dependent manner was demonstrated (Lau et al, 
2004). 
Also, PSP exerted antiproliferative activity on HL-60 cells significantly by 
apoptotic induction and the mechanism involving the apoptotic pathway had been 
extensively investigated (Yang et al, 2005). Bcl-2/Bax ratio and cytochrome c were 
significantly reduced after PSP treatment (100-400 |ig/ml) on HL-60 cells, 
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consistently with the decrease in mitochondrial membrane potential. PSP-treated cell 
population with activation of caspase-3, -8 and -9 was increased dose- and time-
dependently (Yang et al, 2005). Moreover, low doses of PSP (25 |ig/ml) could arrest 
the HL-60 cells at S and G2/M phase with elevation of cyclin E expression (Hui et al, 
2005). This was consistent with another study that PSP inhibited the growth of Molt 
4 leukemic cells via S-phase arrest and apoptosis (Lee et al., 2005). 
Protein-bound polysaccharides (PL) isolated from Phellinus linteus inhibited 
the growth of SW480 human colon cancer cells significantly. Flow cytometry had 
shown that there was an accumulation of G2/M cells and an increment of sub-Gi 
peak dose dependently when various concentrations of PL was incubated with 
SW480 cells (Li et al” 2004). PL-induced apoptosis was further confirmed by 
TUNEL assay which indicated an increased number of apoptotic stained cells in a 
dose-dependent manner as well. Results from the western blotting suggested that its 
inhibitory activity was correlated with the decrease of the Bcl-2 level and increase of 
the cytochrome c level which promoted the occurrence of apoptosis and a decrease of 
cyclin B1 expression so as to delay the G2 to M progression (Li et al, 
‘ 2004).Therefore, PL inhibited the growth of SW480 cells by inducing G2/M cell-
cycle arrest and apoptosis. 
An alkaline-soluble p-glucan extracted from the mycelium of Poria cocos 
was reported to have antiproliferative activity on human breast cancer cell line 
(MCF-7) in our laboratory recently (Zhang et al, 2006b). The proliferation and 
viability of MCF-7 cells were significantly retarded by the P-glucan. Flow cytometry 
analysis suggested that the P-glucan caused cell-cycle arrest at Gi phase and 
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apoptotic induction. It was further revealed by immimoblotting that cyclin D1 and E 
expressions were reduced whereas Bax/Bcl-2 ratio was elevated in p-glucan-treated 
MCF-7 cells. 
1.9 Literature Review on Pleurotus tuber-regium 
In this study, a both edible and medicinal mushroom, Pleurotus tuber-regium 
(PTR), which belongs to the Class Basidiomycetes was investigated. Depending on 
the environmental and culture conditions, PTR can exist in the stage of mycelium, 
fruiting body and sclerotium (Fig 1.5) which is a solid mass of hyphae in its life 
cycle (Ooi, 2000). It is commonly used as an ingredient of soup and sausage and had 
been claimed to have certain medicinal effects such as alleviating headache, stomach 
pain, fever, cold, chest pain, dropsy and smallpox (Zoberi, 1973; Oso, 1977; Ude et 
al, 2001). Antiviral activity of sclerotial PTR polysaccharides, for instance, sulfated 
p-glucans had been reported (Zhang et al” 2004a). However, antitumor activity of 
PTR polysaccharides which was found to be the most remarkable bioactivity had 
拳. 
been extensively investigated (Zhang et al” 2001, 2004b,c, 2006a). 
It has been reported that the fruiting body of PTR was high in protein (Kadiri 
& Fasidi，1990) whereas its sclerotium (Fig 1.5) has over 80% of dietary fiber 
(Cheung & Lee, 1998). Among the various morphological forms of PTR, the 
structure and in vitro antiproliferative activity of sclerotium has been studied most. 
Previous studies have revealed that the hot-alkali sclerotial polysaccharide had a 
main chain of (1—3)-p-glucan with every third unit having a (1^6)-p-D-
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glucopyranosyl branch on average (Deng, 2000; Zhang et al, 2001). Glucose was the 
major monosaccharide in all sclerotial fractions, including hot-alkali, hot-water and 
sonicated ones (Deng et al., 2000; Zhang et al., 2001; Zhang et al” 2004c), the 
efficacy of their in vitro antiproliferation was similar but the carboxymethylated hot-
alkali sclerotial fraction was the most effective fraction in suppressing the growth of 
HL-60 cells. 
Hot-alkali fractions were extracted from the sclerotia of PTR having 
molecular weight of a range from 1.0 xlO^ - 42.2 xlO"^ . The fractions with moderate 
molecular weight (5.8xlO* - IT-lxlO"^) that existed as a random coil had 
antiproliferation towards HL-60 and HepG2 cancer cell lines (Zhang et al, 2001). It 
was shown that the fraction having molecular weight of 17.1xlo4 inhibited the cell 
growth most, showing more than 40% inhibition on HK-60 at 50 |xg/ml and more 
than 60% inhibition on HepG2 cells at 100 |Lig/ml (Zhang et al, 2001). However, the 
hot-water and sonicated fractions having a molecular weight of 43.5x10'^ and 
4.01 xlo4，respectively had only a inhibitory % of less tan 40% against the HL-60 cell 
at 200 )j,g/ml (Zhang et al” 2004c). Besides, the carboxymethylated derivatives of the 
above hot-alkali (1^3)-P-glucans were water soluble had higher molecular weight, 
ranging from 2.08 xio"^  - 53.2 xio*. All the carboxymethylated fractions possessed 
higher in vitro antiproliferative activity towards HL-60 cells (Zhang et al, 2004b). 
Recently, the mechanism for the in vitro antiproliferative activity of this 
carboxymethylated (3-glucan against MCF-7 breast cancer cell line was shown to be 
via Gi arrest by down-regulating cyclin D1 and cyclin E expressions and apoptotic 
induction by lowering Bcl-2 expression and increasing the Bax/Bcl-2 ratio (Zhang et 
al” 2006a). 
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The water-soluble polysaccharides isolated by hot water and ultrasonication 
from PTR mycelia have also been evaluated from their antitumor activity (Zhang et 
al.，2004c). Both mycelial fractions were found to have lower carbohydrate content 
but higher protein content than the sclerotial fractions. Nevertheless, they were 
mainly consisted of glucose. The hot-water and sonicated mycelial fractions had 
higher molecular weight (76.2 xlO"^  and 4.27 xlO"^  MW, respectively) than the 
corresponding sclerotial fractions and also gave stronger growth inhibitory effect 
more than 50% inhibition at 200 ng/ml on HL-60 cells (Zhang et al, 2004c). 
Ifflflj 
Pieur»tus tuber-regium <Fr.> Sing. • 
Figl.5 Sclerotia of Pleurotus tuber-regium (PTR) 
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1.10 Objectives 
Besides the biological response modifying properties, studies on the direct in 
vitro inhibition on cancer cell growth by mushroom non-starch polysaccharides have 
been increasing. Polysaccharides extracted from Lenitnus edodes, Ganoderma 
lucidum, Coriolus versicolor and Poria cocos have been shown to have strong 
antiproliferative activities against different cancer cell lines in vitro (Hui et al, 2005; 
Jiang et al, 2004; Surenjav et al, 2006; Zhang et al, 2006b). Although the 
mechanisms behind these observations still need further investigation, they might be 
related to the pathway controlling the cell-cycle arrest and apoptosis that regulate the 
balance between cell death and cell proliferation so as to eliminate the cancer cells 
without harming the host. 
Previous findings have demonstrated that hot alkali-soluble polysaccharides 
and its carboxymethylated derivatives, as well as hot water-soluble mycelial 
polysaccharides from PTR had potent in vitro antiproliferative activities. However, 
the mechanism was poorly understood. Characterization and bioactivity of 
w 
• polysaccharides extracted from fruiting body and culture medium of PTR have not 
yet been examined. 
In this project, the chemical composition of the extracts from PTR fruiting 
body was evaluated and compared with that of the PTR sclerotial, mycelial and crude 
extracellular extracts investigated previously (Wong, 2004; Zhang et al” 2004c). 
Besides, the in vitro antiproliferative activity of the extracts isolated from PTR 
mycelium, fruiting body and culture medium were studied in order to elucidate the 
plausible mechanism(s) involved which might be associated with cell cycle and/or 
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apoptotic pathways. An in vitro comparative study was carried out to explain the 
structure-activity relationship involved in these mushroom extracts and tumor cell 
antiproliferation. 
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Chapter 2 MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Assay kits 
The protein assay kit was purchased from Sigma (Catalog number: P 5656). 
The cell proliferation ELISA BrdU incorporation assay kit (chemiluminescent) 
(Catalog number: 11669915001) and the annexin-V-FLUOS staining kit (Catalog 
number: 11988549001) were purchased from Roche Applied Science. 
2.1.2 Mushroom samples 
Fruiting bodies of Pleurotus tuber-regium (PTR) (Fig 2.1) were obtained 
from the Sanming Mycological Institute in Fujan of China. PTR mycelia (Fig 2.1) 
were obtained from the submerged fermentation in a 8L fermentor using a basal 
• medium that contained 4g/L yeast extract, Ig/L KH2PO4, 0.6g/L MgS04-7H20 and 
30g/L glucose described previously (Wong, 2004). 
H B1 
Fig 2.1 Fruiting body (left) and mycelia (right) of Pleurotus tuber-regium (PTR) 
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2.1.3 Cell lines and their subculture 
Human acute promyelocytic leukemia HL-60 (ATCC no. CCL-240), human 
chronic myelogenous leukemia K562 (ATCC no. CCL-243), human breast cancer 
MCF7 (ATCC no. HTB-22), human hepatocellular carcinoma HepG2 (ATCC no. 
HB-8065) and monkey normal kidney Vero (ATCC no. CCL-81) cell lines were 
purchased from the American Type Culture Collection (ATCC). Human foreskin 
Hs68 (ATCC no. CRL-1635) was provided by Professor Y.S. Wong of the 
Department of Biology at CUHK. 
The HL-60, MCF-7, HepG2 and Vero cells were grown in Roswell Park 
Memorial Institute (RPMI) 1640 medium (Sigma) (1.5 g/L sodium bicarbonate was 
added, pH was adjusted to 7.4) while the K562 and Hs68 cells were grown in 
Dulbecco's Modified Eagle's Medium (DMEM) (GIBCO) (2 g/L sodium bicarbonate 
was added, pH was adjusted to 7.4). Both media were supplemented with 10% fetal 
bovine serum (FBS) (GIBCO) and 1% antibiotics (100 units/ml penicillin and 100 
|ig/ml streptomycin) (GIBCO). The cells were incubated in a 5% carbon dioxide 
争 humidified incubator at 37°C. Cells with a density of at least 2.5 x 10^  cells were 
cultured in a 25 cm^ tissue-culture flask. 
They were subcultured about every three days according to the ATCC 
guidelines. There were a few differences between the procedure of subculture for 
suspension and adherent cancer cell lines. For the suspension HL-60 and K562 
cancer cells, a part of the cells was transferred into a new tissue-culture flask with 
addition of 7 ml of fresh medium when subculture. For the adherent MCF-7, HepG2, 
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Vero and Hs68 cancer cells, the medium in the tissue-culture flask was first removed 
and washed with phosphate buffered saline (PBS) (pH 7.4) to remove the remaining 
medium that contained trypsin inhibitor. The cells were trypsinized with 1 ml of 
trypsin-EDTA solution (2% EDTA and 2.5 % trypsin solution were diluted by sterile 
PBS) for about 2 minutes until they were all detached from the bottom of the tissue-
culture flask. Together with 4 ml of the corresponding medium, they were subject to 
centrifugation at 1000 rpm for 5 minutes. Cell pellets were resuspended in fresh 
medium and a part of the cell suspension was transferred to new tissue-culture flasks 
which containing 7 ml of fresh medium. 
2.1.4 Antibodies 
Purified mouse anti-human monoclonal antibodies purchased from BD 
Biosciences Pharmingen and Sigma Chemical as listed below. Goat anti-mouse 
secondary antibody was from an Immim-Star Goat Anti-Mouse (GAM)-AP Detection 
Kit purchased from Bio-Rad Laboratories. 
Table 2.1 The antibodies used in determination of expression of proteins 
Approximate 
Primary Catalog Dilution 
Brand molecular 
Antibody Number applied 
weight (kDa) 
Anti-CyclinE BD Biosciences 551160 50 ^250 
Anti-Cdkl/Cdc2 Pharmingen 610037 S 1:2500 
Anti-Cdk2 610145 ^ 1:2500 
Anti-Bcl-2 610539 26 
Anti-Bax 610983 2\ 1:250 
Anti-P-actin Sigma Chemica lA5316 42 1:5000 
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2.2 Extraction of mushroom polysaccharides 
2.2.1 Hot-water extracts from mushroom fruiting body 
The PTR fruiting bodies were first milled into powder a mechanical grinder 
(MFIO, IKA) to a particle size of 0.5 mm and were kept in distilled water (1:25 w/v) 
at 95 for 2 hours with stirring (Fig 2.2). The extraction mixture was centrifUged at 
14000 rpm for 40 minutes and the supernatant was then dialyzed against ultrapure 
water until the total dissolved solute (TDS) was below 10 |ig/ml so as to remove 
molecules with molecular weight smaller than 6000-8000 daltons. The retentate was 
lyophilized by a freeze-drier (LABCONCO 7960013，Freezone). The above 
extraction was repeated twice to obtain a total of three hot water extracts from PTR 
fruiting body designated as HWEl, HWE2 and HWE3, respectively. 
2.2.2 Hot-water extracts from mushroom mycelia 
* The hot-water PTR mycelial extracts were obtained by procedures previously 
described (Wong, 2004). In brief, the mycelium of PTR was homogenized with 
distilled water (1:25 v/v) using a Waring laboratory blender (WARING 8011) at high 
speed and the homogenate was boiled for one hour. The supernatant was obtained 
after centrifugation. The above process was repeated twice to obtain a total of three 
supematants. They were pooled together and mixed with four volumes of 95% 
ethanol overnight to precipitate the polysaccharides. The mixture was centrifuged at 
4800rpm for 5 minutes and then the precipitates were re-dissolved in distilled water 
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and dialysed against distilled water until the total dissolved solute (TDS) was below 
10 ng/ml to remove any small molecules. The retentate containing the PTR mycelial 
hot-water soluble extract was lyophilized and was coded as EDP (Fig 2.3a). 
2.2.3 Exo-polysaccharides from submerged fermentation medium 
Exo-polysaccharides contained in the culture medium of PTR mycelia was 
concentrated and purified by ultrafiltration using a Pall Gelman Maximate System 
with a cassette of MW 10,000 cut off. About 1000 ml of culture medium was 
concentrated by ultrafiltration and then about 4L of distilled water was added to the 
concentrate for washing. The above process was repeated for eight times until the 
TDS was below 5 |ig/ml and the solution was finally concentrated to about 500ml 
(Wong, 2004). After lyophilization, the solid powder containing the PTR exo-
polysaccharide was coded as CEP (Fig 2.3b). 
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Fruiting bodies powder of PTR (20g) 
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Boiling in 500ml of distilled water for 2 hours 




Boiling in 500ml of distilled water for 2 hours Dialyzed and lyophilized 





Boiling in 500ml of distilled water for 2 hours Dialyzed and lyophilized 
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HWE3 
Fig 2.2 Hot water extraction scheme of fruiting bodies of PTR 
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Fig 2.3 The freeze-dried powder of PTR extracts from (a) mycelium and (b) culture medium. 
2.3 Chemical and physio-chemical composition of PTR extracts 
2.3.1 Neutral monosaccharides 
The sugars inside the PTR extracts were first acid hydrolyzed and were then 
converted into alditol acetate derivatives (3.3.1.1 and 3.3.1.2). The neutral sugar 
derivatives of the PTR extracts were separated and analyzed quantitatively by gas 
chromatography (GC) (3.3.1.3) (Blakeney et al, 1983). Besides, the content of acidic 
• i 
sugars was measured by a colorimetric method (3.3.2) based on the Official Methods 
of Analysis (AO AC) method (Theander et al, 1995). 
2.3.1.1 Acid Depolymerization 
About 15 mg of PTR sample was mixed with 0.7 ml of 12M concentrated 
sulphuric acid at 35 for one hour with occasional vortex. The mixture was diluted 
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to 2M sulphuric acid by adding 3.5 ml of distilled water. The acid hydrolysate of the 
sample extract was produced after boiling the mixture at 95 for one hour with 
occasional vortex and cooled under tap water to room temperature. Two standard 
sugar mixtures (1.5 ml of each; Standard I: 0.2005 g of arabinose, 0.2006 g of fiicose, 
0.2004 g of galactose, 0.2006 g of galactosamine, 0.2001 g of glucosamine; Standard 
II: 0.2003 g of glucose, 0.2000 g of mannose, 0.2001 g of rhamnose, 0.2000 g of 
ribose and 0.2003 g of xylose) were prepared and undergone similar acid hydrolysis 
as the PTR samples. 
2.3.1.2 Neutral sugar derivatization 
Three milliliters of the above acid hydrolysates were transferred into new test 
tubes and were cooled in ice followed by the addition of 1 ml of internal standard, 
allose (1 mg/ml). Appropriate amount of 12M and 2M of ammonia were added into 
samples and standards, respectively with thorough vortex-mixing to ensure their 
alkalinity. Five microliters of octan-l-ol which acted as an anti-foaming reagent was 
added to the test tubes. The reduction of the hydrolyzed monosaccharides was done 
• i 
by adding 0.2 ml of freshly prepared sodium boronhydride (200 mg/ml in 2M 
ammonia) and the mixture was kept at 40 for 30 minutes. The mixture was vortex-
mixed with 0.4 ml of glacial acetic acid. An aliquot of the acidified mixture (0.2 ml) 
was transferred to another test tube and was incubated at room temperature for 10 
minutes together with 0.3 ml of 1 -methylimidazole and 2ml of acetic anhydride for 
acetylation. The excess acetic anhydride was degraded by adding 5 ml of distilled 
water with vortex-mixing. After the mixture was cooled to room temperature, 1 ml of 
dichloromethane was added and the mixtures were stood for 10 minutes for phase 
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separation. After the upper layer was removed, the lower layer was washed twice 
with 1 ml of distilled water. The lower layer containing the alditol acetates 
derivatives was dried with anhydrous sodium sulphate and then stored in a vial at -
20°C before GC analysis. 
2.3.1.3 Determination of neutral sugar composition by GC 
The alditol acetates derivatives of the neutral sugars were measured by a GC 
chromatograph (Hewlett-Packard 6890，USA) with an Alltech DB-225 capillary 
column (15 m x 0.25 mm i.d., 0.25 jxm film) and an oven temperature program of 
initial temperature 170°C, followed by a temperature rise of 2°C/min to 220°C with a 
final hold of 10 minutes. The injector and detector temperature was set at 270°C. 
Helium was used as carrier gas and the alditol derivatives were detected by flame 
ionization detector. Calibration was made with the ten monosaccharides mentioned 
above. N-acetylglucosamine was detected as glucosamine because the N-acetyl 
group at C-2 was deacetylated during the sulphuric acid hydrolysis (Pazur, 1994). 
The amount of sugar standards detected was compared with the internal standard to 
monitor recovery because of the losses during the processes of acid hydrolysis and 
derivatization as well as to correct for the different response factors (Rf) of the flame 
ionization detector to individual monosaccharides. The values for monosaccharides 
were expressed as polysaccharide residues (anhydro-sugars) by multiplying the 
amounts of pentoses with a factor of 0.88，hexoses with a factor of 0.90 and 





















































































































































































































































































































































2.3.2 Uronic acid (acidic monosaccharides) content 
The uronic acid content was determined by a AOAC colorimetric method 
(AOAC, 1996). Acid hydrolysate of the PTR sample (0.3 ml), which was obtained 
from the acid depolymerisation (2.3.1.1), was vortex-mixed with sodium chloride / 
boric acid solution (0.3 ml, 2 g sodium chloride and 3 g boric acid were dissolved in 
100 ml distilled water). Five milliliters of 18M concentrated sulphuric acid was 
added to the mixture with vortex mixing. The mixture was kept at 70 for 40 
minutes. After cooling the mixture to room temperature, 0.2 ml of dimethylphenol 
(0.1 g 3,5-dimethylphenol was dissolved in 100 ml glacial acetic acid) was added 
with vortex-mixing and the mixtures stood at room temperature for 10 minutes. 
Glucuronic acid of concentrations at 10|ig/ml，50|ig/ml, 100|ig/ml, 200|ig/ml and 
500|ag/ml were used as standards. The reagent blank was 2M sulphuric acid. 
Absorbance of the sample solutions at 400 run and 450 run against the reagent blank 
were measured. The reading at 400 nm was subtracted from 450 nm to correct for 
the interference from hexoses. The formula for calculating the % acidic 
monosaccharides was shown below: 
% Acidic monosaccharides 
Acidic monosaccharide content derived from standard curve (ng/ml) x 4.2ml* x 100% 
= Sample weight (|ig) 
* total volume of acid hydrolysate 
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2.3.3 Total carbohydrate content 
The phenol-sulphuric acid method was applied to measure the total 
carbohydrate content of the PTR polysaccharides (Dubois et a/., 1956). Acid 
hydrolysate of the PTR samples from 2.3.1 was first diluted 50 times in 2 M 
concentrated sulphuric acid and 0.5 ml of the diluted sample was vortex-mixed with 
0.5 ml of 5% phenol in water. Concentrated sulphuric acid (18M, 2.5 ml) was added 
rapidly and the mixture was allowed to stand for 30 minutes at room temperature. 
The absorbance of the sample was measured by a spectrophotometer (Genesys G5, 
Spectronic) at 490nm and the total carbohydrate content was quantified in reference 
to glucose standards with concentration of 12.5 |xg/ml, 25 jag/ml, 50 jig/ml and 100 
Hg/ml. 
% Total carbohydrate content 
Carbohydrate content derived from standard curve (|ig/ml) x 4.2ml* x 50** 
= X 100% 
Sample weight (jxg) 
* total volume of acid hydrolysate 
警' 
** dilution factor 
2.3.4 Protein content 
Protein content of the PTR samples was quantified by the Lowry assay 
(Lowry et al, 1951) using a protein assay kit (Sigma). Briefly, protein standard 
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solutions (BSA) were prepared for a range from 25 to 200 |xg/ml by distilled water. 
PTR samples were diluted 4 times and made up to a final volume of 1ml solution 
with distilled water. Lowry Reagent Solution (1ml) was mixed with 1 ml of aqueous 
sample solution. The mixture was stood at room temperature for 20 minutes before 
Folin & Ciocalteu's phenol reagent (0.5 ml) was then added to the mixture. The 
blank (distilled water only) and the protein standards were treated similarly to the 
PTR samples. After a 30-minute incubation period, the absorbance of the purple-
color solution was measured by a spectrophotometer (Genesys G5, Spectronic) at a 
wavelength of 750mn. The protein content of the PTR samples was calculated from a 
standard curve of BSA. 
o/o Protein 
protein content derived from standard curve (|xg/ml) x 1ml* x 4** lOO�/ 
Sample weight (jig) 
* Total volume of sample solution 
** dilution factor 
2.3.5 Molecular weight and the homogeneity 
The molecular weight and the homogeneity of the PTR extracts were 
estimated by high pressure liquid chromatography (HPLC) (Waters 600E, Waters). 
Diluted sodium chloride (0.2M) was used as the eluent which was degassed prior 
injection. The samples were dissolved in 0.2M sodium chloride, filtered by the 
0.22jim Millipore filter, and were then passed through a size exclusion column TSK-
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Gel G3000 PW (30 cm x 7.5 mm i.d.; Supelco, Catalog Number: 8-05762) and TSK-
Gel G5000 PW (30 cm x 7.5 mm i.d.; Supelco, Catalog Number: 8-05764) separately, 
with a PWH Guard column (7.5cm x 1.5mm i.d.; Supelco, Catalog Number: 8-
06762). The flow rate of the eluent (0.2M sodium chloride) was 3.0 ml/min and the 
column was kept at 30 The retention time of the PTR extracts and pullulan 
standards (Shodex Standard P-82, Showa Denko) were obtained by the Empower 
software (Waters). Molecular weight of PTR extracts was calculated from a 
calibration curve obtained from the retention time of pullulan standards against the 
log value of their sizes. Refractive index and ultraviolet absorbance at 280 nm were 
used for monitoring the amount of polysaccharides and protein in the PTR samples, 
respectively. 
2.4 In vitro growth inhibitory effects 
2.4.1 Trypan blue dye exclusion method 
Trypan blue dye exclusion method (Zhang et al., 2004c) was applied for 
suspension cells (HL-60 and K562 cancer cells). Cell viability is measured according 
to the ability of viable cells to exclude the dye. Cells were seeded (2.5 x 10^  
cells/well) on a 96-well microplate. The PTR extracts at concentrations of 12.5, 25, 
50, 100，200 and 400 |ag/ml were added, followed by a 72-hour incubation. The 
living cells that excluded the trypan blue dye were counted using a hemacytometer. 
The treatment groups were compared with control having no PTR extracts added. 
The experiments were carried out in five replicates. 
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The above results were expressed as relative % surviving cells calculated as: 
Viable cell number of treatment group 
Relative % surviving cells = x 100% 
Viable cell number of control 
2.4.2 Colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) assay 
MTT assay was applied for adherent cells (MCF-7, HepG2, Vero and Hs68 
cells). Reduction of MTT salt by mitochondrial succinate dehydrogenase gives a 
purplish-blue formazan product, of which amount is measured and reflects the cell 
viability indirectly (Mosmann, 1983). Cells were seeded (2.5 x 10^  cells/well) on a 
96-well microplate. The PTR samples at concentrations of 12.5, 25, 50, 100，200 and 
400 ng/ml were added after the cell attachment and incubated for 72 hours. The cell 
viability was detected by a microplate reader (SpectraMAX 250) at 570nm as 
,described by Mosmann (1983). The treatment groups were compared with controls 
• without adding any PTR samples. The experiments were carried out in five replicates. 
The above results were expressed as relative % proliferating cells calculated as: 
Absorbance of treatment group 
Relative % proliferating cells = x 100% 
Absorbance of control 
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2.5 In vitro cell proliferation assay 
An ELISA BrdU incorporation assay (chemiluminescent) which is based on 
the incorporation of pyrimidine analogue, BrdU, into the DNA in the S phase of 
proliferating cells was used to measure cell proliferation. The procedures were 
generally based on an ELISA BrdU kit (Roche Applied Science; Catalog number: 
11669915001). In brief, 1 x 1cells/well were seeded on a 96-well microplate. The 
PTR samples at concentrations of 12.5, 25, 50, 100，200 and 400 |ig/ml were added, 
followed by 72-hour incubation. Ten microliters of BrdU labeling solution was 
added in each well and the plate was incubated for 2 hours at 37°C to allow BrdU 
incorporated into the DNA-synthesizing cells. The solutions in each well were 
discarded and the wells were dried in 60 oven for an hour. After that, cells were 
fixed and denatured with 200 |xl FixDenat solution for 30 minutes and were then 
incubated with 100|il/well of anti-BrdU-POD working solution for 90 minutes at 
room temperature. The cells in each well were washed by 200|j1 washing solution 
three times to remove the excess antibody conjugates. After removing the washing 
solution, the cells were incubated with the 100 |il substrate component solution in 
dark for three minutes with shaking. The chemiluminescent light emitted was 
• measured by a luminometer (ML3000 microtiter® plate luminometer, Dynatech 
Laboratories). The treatment groups were compared with controls without treatments. 
The experiments were carried out in five replicates. 
The results were expressed as relative % proliferating cells calculated as: 
Chemiluminescence of treatment group 
Relative % proliferating cells = x 100% 
Chemiluminescence of control 
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2.6 Cell-cycle analysis 
The effect of the PTR extracts on the cells was assessed by flow cytometry 
which can quantify the cell-cycle phase distribution. Various cell densities were 
grown in 25 cm culture flasks for 24 hours, 48 hours or 72 hours. The treatment 
groups were co-incubated with PTR samples at an appropriate concentration 
according to the results in 3.5. After the incubation, cells were collected into a test 
tube and centrifuged at 300 g for 10 minutes. The medium was discarded and the cell 
pellet was washed with 2 ml of PBS twice followed by centrifugation at 300 g for 10 
minutes in between and then fixed in 70% cold ethanol. The fixed cell pellet was 
stored at -20 °C until the day before analysis. 
Prior for the cell-cycle analysis, the ethanol inside the test tube was removed 
after centrifuging at 300 g for 10 minutes and then washed with 2 ml of PBS twice as 
described above. The cell pellet was then resuspended in 1 ml of solution containing 
0.005 g/100 ml propidium iodide (PI) and 0.001 g/100 ml RNase A (0.121 g/100 ml 
of Tris-base was added; pH 8.0). The test tube was kept at 4 overnight. The PI-
stained cell was transferred to a specific tube by filtering the cell clumps by a piece 
备 of nylon mesh placing on the mouth of the specific tube. Cell-cycle of the treated 
cells was detected by a EPICS-XL flow cytometer (Beckman Coulter, Miami, FL) 
with cell debris being excluded. Cell-cycle distribution was analyzed using the 
multicycle software from Phoenix Flow Systems, San Diego, CA. A DNA histogram 
with sub-Gi，Gq/Gi, S and G2/M phases was constructed. 
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2.7 Apoptotic determination 
Annexin V/PI staining assay can distinguish and divide cells into early 
apoptosis, late apoptosis and viable by detecting the changes of cell membrane 
permeability and the presence of phosphatidylserine (PS) on the cell surface 
(Engeland et al, 1998). The procedures were based on an Annexin-V-FLUOS 
Staining Kit followed with some modifications. The density of the cells used and the 
general procedures were the same as cell cycle analysis (2.6). After co-incubated 
with the PTR extracts, the cells were counted by a hemacytometer. An amount of 
1x10^ cells was added into three centrifuge tubes separately, followed by washing 
with PBS twice and an addition of 100 |xl of Annexin-V-Fluos labeling solution, 
fluorescein (FITC) solution and PI solution, respectively. The mixtures were kept in 
dark for 15 minutes and then centrifuged at 300 g for 5 minutes to obtain the cell 
pellets, which was then resuspended in 0.5 ml of Incubation Buffer. Positive controls 
were prepared for calibration by adding 3% formaldehyde into a flask of cultured 
cells and incubated for 10 minutes. In the culture flask, an amount of 1x10^ cells was 
added to three centrifuge tubes separately. The positive controls were treated and 
stained similarly as the samples. After removing the cell clumps by a piece of nylon 
• mesh, the apoptotic cells were determined by the EPICS-XL flow cytometer using 
488 run excitation and 515 run and >600 nm bandpass filters for FITC and PI 
detection, respectively. 
2.8 Expression of proteins involved in apoptosis and cell-cycle 
Western blot was employed to determine the protein expression in the cells 
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treated with PTR extracts. Proteins isolated from the treated cells were separated by 
sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). The 
protein of interest was detected by western blot (Mini-PROTEAN 3 Electrophoresis 
System; Bio-rad Laboratories). 
2.8.1 Preparation of cell lysates 
A density of 2.5 x 10^  cells/ml cells was cultured in a 75 cm^ tissue-culture 
flask and was co-incubated with the PTR extracts at the same concentration used in 
flow cytometry for the 24，48 and 72 hours. The cells were centrifuged at 300 g for 
10 minutes and the cell pellet was washed with PBS twice. The cell pellet was then 
lysed by 0.1 ml of ice-cold lysis buffer containing 2 jxl of protease inhibitor cocktail 
(BD Biosciences Pharmingen; Cat No.: 554779) for one hour at 4°C with occasional 
vortexing. The cell lysate was transferred into a 1.5 ml microtube and subjected to 
centrifugation at 12,000 rpm for 5 minutes. The supernatant was transferred to a new 
microtube and was kept at -20°C before determination of protein concentration. 
2.8.2 Determination of protein concentrations 
The protein content in the cell lysate was quantified by the BCA protein assay 
using BSA protein standard through the measurement of absorbance at 562nm by a 
mircoplate reader. A set of BSA standards at concentration of 12.5, 25, 50, 100，200 
and 400 |xg/ml was prepared. The sample was diluted by distilled water 50-fold. One 
hundred microliters of working reagent from the BCA protein assay kit was added 
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(50 parts of reagent A was vortex-mixed with one part of reagent B) into both sample 
and BSA protein standards. The microplate was incubated at 37°C for 30 minutes and 
the absorbance was then measure by the mircoplate reader (SpectraMAX 250, Gene 
Co. Ltd.) at 562 run. The protein concentration was compared and calculated in 
comparison with the BSA standard curve as follows. 
Actual protein concentration (|ig/|il) in sample 
=Protein concentration (|xg/ml) derived from the standard curve x 50* x 1000** 
* dilution factor 
** conversion factor 
2.8.3 Western blot 
Thirty to sixty micrograms of protein from cell lysate was required. The 
loading in each lane of samples consisted of 10 |j-l of 2x loading dye and a calculated 
volume of desired protein amount. Distilled water was added to make up the final 
loading volume to 20 The sample was heated for 5 minutes at 95�C in a 
Theraiomixer comfort (Eppendorf, company) before loading. 
The proteins in the cell lysate were packed on 5% stacking gel and 
electrophoresed on 12% SDS separating gel. The two glass plates were washed with 
water and 70% ethanol, respectively. The glass plates were held by the casting frame. 
Around 5 ml of 12% SDS separating gel was first added in between the two plates. 
The bubbles inside the glass plates were removed by gently knocking the glass plate. 
The gel was covered and flattened by isopropanol. After 40 minutes for gel 
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polymerization, isopropanol was poured off and absorbed by filter paper. After that, 
5% stacking gel was added on the top of the separating gel and the comb was 
inserted. The gel was stood for 15 minutes. 
After the gel was polymerized, the comb was removed and the glass plates 
were put into the tank for western blotting. The center of the tank was fully filled 
with Ix running buffer (14.4 g glycine, 3.03 g Tris-base and 1 g SDS were dissolved 
in IL of distilled water) to ensure the wells were covered by it. Ten microliters of 
Precision Plus Protein dual color standards (Bio-Rad Laboratories) and 20 |il of 
sample were loaded into the wells using fine-tipped pipettes. The standard marker 
and the sample were migrated on the stacking gel at 60V and were separated on the 
separating gel at 120V until the end-point of the electrophoresis which was 
determined by the pre-stained protein standard marker. 
The separated proteins on the polyacrylamide gel were transferred to the 
Immuno-BlotTM PVDF membrane, 0.2 |a,m for protein blotting (Bio-rad Laboratories, 
Catalog: 162-0177). The membranes were first pre-wetted by methanol. Then, the 
sponges，filter papers and the pre-wetted membranes were shaken in freshly-prepared 
• Ix transfer buffer (14.4g glycine and 3.03g Tris-base were dissolved in 800 ml of 
distilled water, followed by an addition of 200 ml of methanol). The membrane 
sandwich was assembled based on the kit instructions with the following sequence 
from the negative side to the positive side: sponge, filter paper, gel，membrane, filter 
paper, and then sponge. Bubbles were squeezed out from the membrane sandwich 
with the help of a test tube. After placing it and the ice block into the transfer tank, it 
was fully filled with Ix transfer buffer. The transfer process was carried out at llOV 
for one hour on a hot-plate with continuous stirring to keep a constant heat flow. The 
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membrane was then shaken in the freshly-prepared blocking buffer (0.5% Auora milk 
powder and 0.5% Tween 20 were dissolved in Ix PBS) for one hour. 
The membrane was kept in a 50 ml centrifuge tube, probing with 3 ml of the 
corresponding primary antibody which was diluted by the blocking buffer according 
to the recommendation (Table 3.1). The centrifuge tube was rotated in a 
hybridization oven kept at 4 °C overnight. The membrane was then washed by PBST 
(0.5% Tween-20 was dissolved in Ix PBS) on a shaker for 15 minutes. It was then 
probed with 3 ml of the goat anti-mouse secondary antibody conjugated to alkaline 
phosphatase (AP) which was diluted by the blocking buffer (dilution: 1:3000) for an 
hour at room temperature. After washing the membrane by PBST on a shaker for 30 
minutes, it was kept in the PBST until the detection process was performed. 
The protein of interest was visualized by the chemiluminent protein detection 
system. One milliliter of detection substrate buffer from the Immun-Star Goat Anti-
Mouse (GAM)-AP Detection Kit (Bio-Rad Laboratories) was added on the 
membrane for 5 minutes. Finally, in the dark room, the membrane was covered by an 
X-ray film in a film cassette with an optimal time and the film was developed by the 
X-ray film processor (Kodak). 
Anti-p-actin antibody was used as a loading control. After the membrane was 
rinsed by PBST, it was then placed into a sealed box and was shaken in the stripping 
buffer at 50°C for 20 minutes in an orbital shaker. The membrane was then rinsed by 
PBST again to remove the remaining stripping buffer. After that, it was shaken in the 
blocking buffer for one hour. It was re-probed with anti-P-actin primary antibody and 
detection was made according to the procedures described above. 
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The western blot was scanned and quantified with the software LumiAnalysis 
3.1 of Lumi-Imager (Roche Molecular Biochemicals). The integrated values for each 
band were taken and their ratios against p-actin were calculated. 
integrated value of band for sample 
Relative quantity of the band for sample = 
integrated value of band for (3-actin 
Normalized band value Relative quantity of the band for sample = x 100% 
for sample(%) Relative quantity of the control band 
2.9 Statistics 
Data in all the assays were statistically assessed by Student's t-test and 
differences with a p-value of less than 0.05 were considered significant. The dose-
response curves were plotted using the GraphPad PRISM® software. 
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Chapter 3 RESULTS AND DISCUSSION 
3.1 Yield of extract samples isolated from different developmental stages of 
PTR 
Hot-water extraction is commonly used since hot water extracts obtained 
from other edible mushrooms usually have exhibited strong antitumor activities 
(Chihara, 1969; Ikekawa, 1968, 1969), particularly those extracted from the fruiting 
bodies and mycelia (Reshetnikov, 2001). Hot water extract of Agaricus hisporous 
inhibited the growth of SI80 and Ehrlich sarcoma cells by 90% and 100% in vitro, 
respectively (Ying et al., 1987). Intravenous administration of insoluble (1^3)-P-D-
glucans from yeast cell wall had raised many side effects such as hepatoplenomegaly 
(Riggi & Di Luzio, 1962)，granuloma formation (Williams et al., 1985), micro-
embolization and enhanced endotoxin sensitivity (Browder et al, 1987). Hot water 
extracts would not cause this problems and therefore facilitate their medicinal and 
clinical applications (Zhang et al., 2004b). Moreover, the conformation of 
polysaccharides which is believed to be necessary for antitumor activity would be 
retained more easily than other treatments like alkaline extraction (Hobbs, 2005). 
Why made 3 extracts?The yield of the three hot-water extracts (HWEs) 
obtained from the fruiting bodies of PTR, HWEl, HWE2 and HWE3, was 7.65%, 
2.04% and 2.08%, respectively (Table 3.1). The yield was comparatively higher than 
that of three hot-water extracts sequentially isolated from the fruiting body of 
Agaricus blazei at 121 °C for two hours (Ohno et al, 2001)，of which was 3.2%, 
0.5% and 0.4%, respectively. Usually, most water-soluble molecules are extracted 
preferentially in the first round of extraction. The yield of all the PTR extracts, 
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including the sclerotial one (SCP) investigated previously, was below 10% (Table 
3.1). The low yield of hot-water extraction (less than 10% dry weight) is common in 
other mushroom polysaccharides as well. Since polysaccharides have high molecular 
weight with different conformations and degree of branching, they can form gel or 
precipitate in aqueous solutions easily (Mizuno et al, 1995). Increase in the 
extraction temperature could enhance the degree of solubility of polysaccharides in 
aqueous solutions. However, extraction temperature of 95 was still employed in 
this project because excessive heating would reduce the molecular weight of 
polysaccharides and disrupt their conformation which could not be regained after 
cooling (Hobbs, 2005). The triple helix structure of Schizophyllan was lost after 
heating above 135 (Brant et al, 1997). 
The yield of mycelial extract of PTR (EDP) (4.38% dry weight) was 
consistent with that obtained previously (4% dry weight) (Zhang et al., 2004c) (Table 
3.1). The relatively higher yield of EDP obtained might be due to the fact that the 
mycelia were extracted twice more than the previous study. On the other hand, the 
yield of EDP was high when comparing with the mycelial polysaccharides extracted 
‘ from Poria cocos of various strains and culti^e media by hot water, ranging from 
only 1.7% to 3.1% only (Jin et al, 2003). 
The yield of extracellular extract of PTR (CEP) was only 0.09Ig dry weight 
per liter of culture medium of PTR mycelial fermentation (Table 3.1), which was 
much lower than those obtained from Ganoderma lucidum and Ganoderma tsugae, 
which were 0.85g and 0.5g per liter of culture medium, respectively (Sone et al., 
1985, Peng et al.’ 2003). 
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Table 3.1 The yield, total carbohydrate and protein content of the PTR extracts. ^ 
Developmental stage PTR extracts Yield Total carbohydrate Protein 
content content 
Culture medium* ^ 0.091' 83.4士 1.30 15.9士0.19^ 
Mycelium* EDP 4.38 87.2士4.73 3.24士 0.14 
Fruiting body HWEl 7.65 42.4士2.90 35.4士0.80 
HWE2 2.04 45.3士0.69 30.4士 0.88 
HWE3 2.08 32.0士 3.36 36.1±0.10 
Sclerotium ** SCP 3.60 77.0 5.10 
a % dry weight, ^ g dry weight/L 
• data from Wong, 2004 
** data from Zhang et al.，2004c 
3.2 Chemical characteristics of hot-water extracts isolated from different 
stages of PTR 
3.2.1 ” The total carbohydrate and protein content of PTR extracts 
i 
V 
The carbohydrate content of PTR extracts was determined by using glucose 
as standard in the phenol-sulphuric assay while their protein content was determined 
by the Lowry method using BSA protein as reference. Both CEP and EDP were high 
in total carbohydrate content, which were accounted for 83.4% and 87.2%, 
respectively (Table 3.1). This was concomitant with their low protein content, which 
were 15.9% and 3.24%, respectively (Table 3.1). Therefore, polysaccharides were the 
major constituent in these two extracts, with protein as the minor component. 
60-
The water-soluble mycelial polysaccharides of PTR isolated from previous 
study had 51% of carbohydrate and 10.7% of protein (Zhang et al” 2004c). The 
small variations in the chemical composition between the present results with those 
obtained previously was reasonable as different extraction process and conditions 
were adopted. In previous study, the powder mycelia was first defatted and 
suspended in 0.9% sodium chloride solution, followed by boiling at 100°C for 3 
hours once. The mycelial polysaccharide was obtained after dialysis and 
lyophilization. However, in the present study, the mycelia were extracted by hot 
water three times and then ethanol-precipitated before dialysis. It is believed that the 
extraction conditions applied in the present study could isolate the mycelial extract 
with higher carbohydrate content and comparatively larger amount of 
polysaccharides. Water soluble sclerotial polysaccharides (SCP) of PTR was also 
high in carbohydrate content (77%) but only small amount of protein (5.1%) was 
found (Zhang et al., 2004c) (Table 3.1)，matching its high content of dietary fiber 
(>80%) (Cheung & Lee, 1998). 
.On the contrary, the three HWEs isolated from the fruiting body had a 
‘ comparatively lower total carbohydrate content ranged from 32.0% to 46.1% but 
much higher protein content of over 30% (Table 3.1). These results were reasonable 
as it has been revealed that the fruiting body of PTR was high in protein (around 
lOg/lOOg) (Akindahimsi and Oyetayo, 2006; Kadiri & Fasidi, 1990). While the total 
carbohydrate content, in descending order, was HWE2, HWEl and HWES. The 
protein content in decreasing order showed an opposite trend of HWE3, HWEl and 
HWE2 (Table 3.1). Therefore, the difference between carbohydrate and protein 
amounts was the largest in HWE2. However, similar amounts of total carbohydrate 
and protein (ratio in terms of % dry weight: 0.9:1) was observed in HWE3 
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3.2.2 The monosaccharide composition of PTR extracts 
The monosaccharides in PTR extracts (except acidic monosaccharides which 
was analyzed by a colorimetric method separately) could be separated and detected 
by gas chromatography (GC). Based on the result of GC, although glucose was 
dominant in HWEs, a considerable percentage of mannose and galactose, and a 
minor amount of ribose were obtained. This suggested that there might be more than 
one monosaccharide made up the backbone of the polysaccharides of HWEs. When 
comparing the three HWEs, the proportion of glucose and uronic acids was 
increasing from HWEl to HWE3 but other monosaccharides, including mannose, 
galactose and ribose, were decreasing (Table 3.2). It was suggested that more than 
one type of polysaccharides might present in the HWEs. 
N-acetylglucosamine, derived from chitin which is a structural cell wall 
polysaccharide in fungi, was only found in CEP and EDP. Obviously, glucose was 
the major monosaccharides in EDP, suggesting glucan was probably the main type of 
polysaccharides in the PTR mycelium. Similarly, water-soluble mycelial 
polysaccharides investigated previously found glucose was the major sugar (73.1%), 
with small amount of galactose, mannose, glucosamine and uronic acid (14.3%, 
9.4%, 3.1% and 0.5%, respectively) (Table 3.2). The mycelial polysaccharides 
isolated from wild strain Poria cocos (a sclerotium-forming mushroom similar to 
PTR) cultivated in a medium containing com steep liquor was also glucose-dominant 
(70.7%) (Jin et al., 2003). On the other hand, mannose was the main 
monosaccharides in CEP. It was common that high mannose content was found in 
exo-polysaccharides, such as that isolated from the Poria cocos mentioned above, 
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consisted of 61.7% mannose (Jin et al., 2003). 
The content of acidic monosaccharides, for instance, glucuronic acid and 
galacturonic acid, were estimated by the total amount of uronic acids. Despite of the 
fact that CEP had 3.25% of uronic acids which was the highest, all of the PTR 
extracts consisted of less than 1% of uronic acids (Table 3.2). Thus, the content of 
acidic monosaccharides in PTR extracts was considered as low and insignificant. 
In summary, three kinds of monosaccharides involving glucose, mannose, 
and galactose were detected in all fractions but in different proportions. Except the 
mannose-rich CEP, glucose was most dominant in three HWEs, EDP and SCP 
(Zhang et al, 2004c) but the amount of mannose and galactose in the HWEs was 





Table 3.2 The monosaccharide composition of the PTR extracts ® 
Monosaccharide PTR extracts 
composition 
EDP* CEP* SCP** HWEl HWE2 HWE3 
Rhamnose 0.55 n.d.卜 nid! rTd! nid! iTd 
Fucose 0.14 0.30 n.d. n.d. n.d. n.d. 
Ribose 0.06 n.d. n.d. 7.66 6.48 4.24 
Arabinose 0.08 n.d. n.d. n.d. n.d. n.d. 
Xylose 0.09 0.29 n.d. n.d. n.d. n.d. 
Mannose 4.76 76.0 7.70 26.9 21.8 20.4 
Galactose 3.35 5.37 6.90 16.3 15.4 14.8 
Glucose 87.3 7.10 85.4 49.2 56.3 60.5 
Glucosamine 2.69 4.68 n.d. n.d. n.d. n.d. 
Galactosamine n.d. 2.99 n.d. n.d. n.d. n.d. 
Uronic acids 0.95 3.25 n.d. 0.29 0.58 0.70 
a % monosaccharide of total carbohydrate 
b n.d. not detectable 
* data from Wong, 2004 
** data from Zhang et al” 2004c 
« 
‘ 3.3 Molecular weight distribution of PTR extracts 
In order to determine the structure of PTR extracts, their molecular weight 
distributions and homogeneities were examined by HPLC. A TSK-Gel G5000PW 
and a G3000PW columns were chosen in HPLC for analyzing the water-soluble PTR 
extracts. The hydrophilic resin has excellent chemical and mechanical stability 
between pH2 and 12. The G5000PW column has a particle size of IT i^m with pore 
size of 1000A whereas G3000PW has a particle size of lOfim with pore size of 200A. 
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There two columns were employed so that a broad range of molecular weight 
distribution could be determined. 
The molecular weight of PTR HWEs was estimated by the TSK3000PW 
column. Two peaks of 0.10 xlO'^  and 1.32 xl04, and another peak of larger than 21.2 
xl04 were detected by the RI detector (Data not shown). The SEC chromatogram 
indicated that all small molecules were successfully removed by extensive dialysis. 
Also, TSK3000PW was not efficient enough to separate and analyze the polymers of 
larger molecular weight because the pullulan standards P200-P800 were overlapping 
(Fig 3.1). When analyzing by G5000PW column, the pullulan standards were well 
separated (Fig 3.2). Three obvious fractions were determined in the three HWEs 
chromatograms with molecular weight ranging from 0.5 xlO^ to 185.5 xlO^ in 
reference to pullulan standards (Table 3.3). It was not surprising that more than one 
fraction was found in PTR HWEs since they were only crude water extracts. 
Polysaccharides in the fruiting bodies of mushroom are usually very heterogeneous. 
However, the molecular weight of Fraction 3 was much lower than those of 
polysaccharides isolated from other mushrooms which were well-known for their 
‘ antitumor activities. For example, Lentinan and Schizophyllan had a MW of 50 xlO"^  
V A 
and 45 xlO (Mizuno et al, 1995). Thus, only Fractions 1 in HWEs was considered 
as the most potential antiproliferative polysaccharides. UV detector was specified 
for the presence of protein. Obviously, strong UV absorbance was observed in 
fraction 1 and 3 of all three PTR HWEs (Fig 3.3b, 3.4b and 3.5b), implying certain 
amount of protein was associated with the polysaccharides which was consistent with 
the high protein content of PTR HWEs (3.2.1). 
In the chromatograms of all PTR HWEs, fraction 1 of HWE2 had highest 
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molecular weight (185.5 x MW). Besides, the major fraction in HWE3 was the 
high-molecular-weight fraction 1. It might be that the polysaccharides obtained are 
mainly originated from the cell wall of mushroom. Those compounds with small 
molecular weight were easily released out and was extracted preferentially in the first 
extraction. By applying a longer boiling time, the cell wall would be further 
fragmented and therefore those with higher molecular weight which located in the 
inner cell wall could be isolated in the subsequent extraction. Besides, it might be 
possible that the three fractions obtained in three HWEs had different degree of 
branching. Evidence showed highly-branched p-glucans are located at the outer cell 
surface while linear P-glucans are linked with chitin covalently (Beelman et al., 
2003). Therefore, more branched polysaccharides might exist in fraction 2 and 3 
whereas fraction 1 might contain more linear polysaccharides. Interestingly, HWE2 
has the highest molecular weight among the three PTR extracts, suspecting that 
HWE2 might have a more expanded conformation and therefore a higher molecular 
weight was measured by the SEC HPLC. Further investigation was required for 
confirmation. 
» 
* CEP had the smallest molecular weight of 4.41 xlO* (Wong, 2004) whereas 
the molecular weight of HWEs was the largest. EDP and SCP consisted of two major 
»• A 
fractions, but mainly composed of that with higher molecular weight (50.9x10 MW 
and 43.5x10"^ MW, respectively) (Wong, 2004; Zhang et al., 2004c). Two fractions 
were also detected from mycelial polysaccharides isolated previously from PTR and 
the molecular weight of the major one was 76.2x1 O* (Zhang et al.’ 2004c). Such 
phenomenon commonly occurred as different extraction conditions was used and so 
different polysaccharides would be isolated. For example, lentinan isolated from 
Lentinus edodes was a (1—3) - f -D -glucan with MW of about 5 xlO^ (Mizimo et al” 
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1989) whereas a polysaccharides isolated from similar process mainly consisted of 
D-glucose had MW of 20.3 xlO"^  (Zheng et aL, 2005), and an ethanol-based extract 
of L edodes which had molecular weight of a 1.4x10'* revealed by SEC HPLC (Gu, 
2005). 
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Fig 3.1 The SEC profile of pullulan standards by a TSK3000PW column at 30°C 
with sodium chloride (0.2M) at a flow rate of 3.0 ml/min and RI detection. 
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Fig 3.2 The SEC profile of pullulan standards by a TSK5000PW column at 30°C 
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Fig 3.3 The HPLC chromatogram of HWEl obtained by a TSK5000 column with 
detection by refractive index (black line) alone and together with UV absorbance 
(blue line). The eluent was 0.2M sodium chloride at a flow rate of 3.0 ml/min and the 
column was kept at 30°C. 
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Fig 3.4 The HPLC chromatogram of HWE2 obtained by a TSK5000 column with 
detection by refractive index (black line) alone and together with UV absorbance 
(blue line). The eluent was 0.2M sodium chloride at a flow rate of 3.0 ml/min and the 
column was kept at 30°C • 
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Fig 3.5 The HPLC chromatogram of HWE3 obtained by a TSK5000 column with 
detection by refractive index (black line) alone and together with UV absorbance 
(blue line). The eluent was 0.2M sodium chloride at a flow rate of 3.0 ml/min and the 
column was kept at 30°C. 
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Table 3.3 The molecular weight (Mv； of the PTR HWEl, HWE2 and HWE3. 
Sample Fraction 1 Fraction 2 Fraction 3 
M^xlO'' Peak area % M^xW* Peak area % Peak area % 
HWEl ^ \ 2 26.47 05 60.94 
HWE2 185.5 18.87 1.2 29.87 0.6 41.83 
HWE3 174.9 29.98 1.2 26.22 0.6 29.20 
3.4 Chemical characterization of PTR extracts 
PTR extracts isolated from different developmental stages varied 
considerably both in terms of chemical composition and molecular weight. Based on 
the chemical characterization of PTR extracts, their possible structures could be 
deduced. 
Previous study found that EDP and CEP had very high carbohydrate content 
but low in protein content (Wong, 2004). It is believed that they belonged to different 
types of polysaccharides according to their monosaccharide profile. Glucose was the 
« 
major monosaccharides obtained in EDP and whereas CEP was rich in mannose, so 
they were proposed to be glucan and mannan, respectively (Wong, 2004). Three 
HWEs contained substantial amount of protein and the fraction 1 and fraction 3 were 
found along with strong UV absorbance in HPLC analyses, suggesting the 
polysaccharide might couple with protein and they were therefore likely to be 
polysaccharide-protein complexes. Fraction 2 of PTR HWEs was speculated to be 
pure glycan. It is believed that the polysaccharide portions were made up of glucose, 
mannose and galactose. GC results showed that % glucose and % uronic acid were 
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increased while % mannose and % galactose were decreased from HWEl to HWE3. 
Meanwhile, fraction 1 was the major fraction in HWE3 while fraction 3 was 
dominant in HWEl, speculating that fraction 1 was made up of glucose and fraction 
3 was made up of mannose and galactose. It suggested that fraction 1 and fraction 3 
of HWEs might be glucan and mannan/galactan/mannogalactan, respectively. 
The hot-alkali sclerotial polysaccharides have been revealed to be a glucose-
rich (l->3)- p-glucan with every third unit having a (1 ->6)-(3-D-glucopyranosyl 
branch on average (Deng, 2000; Zhang et a/.,2001). It seemed that the water-soluble 
sclerotial polysaccharide was also glucans as the percentage of glucose was over ten-
fold of that of mannose and galactose. 
The chemical composition and molecular weight of PTR extracts was totally 
different from each other. HWEs from fruiting body, having the highest molecular 
weight and protein content, contained three fractions. EDP and sclerotial 
polysaccharides with moderate molecular weight (50.9x10'^  MW and 43.5x10"^ MW, 
respectively) were rich in glucose (Wong, 2004; Zhang et al” 2004c). CEP with 
‘ relatively low molecular weight was rich in mannose (Wong, 2004). According to the 
present results, HWEs were assumed to be polysaccharide-protein complexes 
composed of different monosaccharides, EDP and CEP was speculated to be glucan 
and mannan, respectively. 
70-
3.5 Cytotoxic effect of PTR extracts on various cell lines in vitro 
Four human cancer cell lines were employed to assess the in vitro 
cytotoxicity and antiproliferaive activities of PTR extracts. They were originated 
from different organs and cancer types, including acute promyelocytic leukemia 
(HL-60), chronic myelogenous leukemia (K562), breast cancer (MCF-7) and liver 
cancer (HepG2). All of them are model cell lines used by Drug Research and 
Development of the National Cancer Institute in screening for potential antitumor 
agents and studying cell cycle and apoptosis pathway (Hui et al” 2005). Besides, two 
normal cell lines, one from monkey kidney (Vero) and one from human foreskin 
(Hs68) were applied to test the cytotoxicity of PTR extracts on normal cells, if any. 
3.5.1 Effect of PTR extracts on HL-60 cell viability 
In general, all the PTR extracts from a concentration of 12.5 ng/ml to 400 
|ag/ml could inhibit the HL-60 cells significantly (Fig 3.6). PTR HWEs reduced the 
cell viability significantly in a dose dependent manner, however, HWEl was less 
� effective than HWE2 and HWE3 in terms of LC50 value of the growth inhibitory 
, effect of HWEl, HWE2, and HWE3 estimated 50% at 100 ^ig/ml, 25 ^ig/ml and 50 
|xg/ml, respectively. 
On the contrary, the number of HL-60 surviving cells remained high in CEP 
and EDP treatment from 12.5 |xg/ml to 200 |xg/ml (Fig 3.6). However, CEP lowered 
the relative surviving HL-60 cells sharply from 78.8% at 200 ^ig/ml to 13.0% at 400 
^ig/ml (Fig 3.6). The relative surviving HL-60 cells was also reduced by EDP from 
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65.7% at 200 |ig/ml to 34.9% at 400 [ig/ml. These suggested that their cytotoxicity 
was most effective at 400 jxg/ml among the concentrations tested. The estimated LC50 
value of CEP and EDP was both about 300 jig/ml. Water-soluble PTR mycelial 
polysaccharides had been shown to have 80% inhibition (20% surviving cells) on 
HL-60 cells at 200 i^g/ml previously (Zhang et al., 2004c). The difference in the 
inhibitory effect of EDP obtained from the present result and the previous study 
might be due to the difference in their molecular weight distribution. The mycelial 
polysaccharides extracted previously consisted of a major peak of 76.2 xlO"^  MW 
whereas EDP consisted of a major peak of 50.9 xlO"^  MW. Polysaccharides with 
higher molecular weight usually possess enhanced antitumor activities (Bohn and 
BeMiller, 1995). Besides, water-soluble sclerotial polysaccharides exhibited less than 
40% growth inhibition (more than 60% surviving cells) on HL-60 cells at 200 |ig/ml 
(Zhang et al., 2004c) as compared with other PTR extracts. 
In summary, cytotoxicity of PTR extracts towards HL-60 cells varied. HWEs 
could significantly reduce the percentage of viability of HL-60 cells in a dose-
dependent fashion, among which HWE2 was the most potent. Cell viability was only 




0100. I T T • • 
^ 9 0 . ！ ^ ：：. I • H W E 2 
， • H W E 3 
I： N|Xt 
1： 
^ 0—1 ••丨 i T V i f： 
0.00 1.0 1.2 1.4 1.6 1.8 2.0 2.2 2.4 2.6 
Log concentration (fig/ml) 
• Fig 3.6 The effect of concentrations of PTR extracts on the viability of HL-60 cells 
determined by trypan blue exclusion method was expressed as the viability %, mean 
士S.D. (n=5), against the log concentration of extracts. Different letters represent the 
. significant difference between the means of the number of cells in control group and 
treatment group by Student's t-test (*p< 0.05, # p< 0.01). 
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3.5.2 Effect of PTR extracts on K562 cell viability 
Obviously, the relative % of surviving K562 cells was reduced the most by 
CEP and HWE2, in which the relative % of surviving cells was found to be smaller 
than 20% at all tested concentrations (Fig 3.7). Strong growth inhibitory effects was 
maintained even at 12.5 ^g/ml for CEP- and HWE2-treated cells, suggesting the 
bioactive components were very potent and a lower concentration might also give 
significant inhibition on K562 cells if tested. Although HWE3 could not retard the 
K562 cell viability as much as HWE2 and CEP, the relative % of surviving cells was 
decreased from 52.9 % at 12.5 |ig/ml to 27.0 % at 400|ig/ml. The estimated LC50 
value of HWE3 was 12.5 |ig/ml. The percentage of K562 surviving cells was the 
least affected by HWEl and EDP which has a relative % of surviving cells of 63.3% 
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Fig 3.7 The effect of concentrations of PTR extracts on the viability of K562 cells 
. determined by trypan blue exclusion method was expressed as the relative % 
surviving cells, mean 土S.D. (n=5), against the log concentration of extracts. Different 
letters represent the significant difference between the means of the number of cells 
in control group and treatment group by Student's t-test ( p< 0.05, p< 0.01). 
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3.6.5 Effect of PTR extracts on normal cell proliferation 
Not all the PTR extracts could inhibit MCF-7 cell proliferation significantly. EDP, 
HWEl and HWES only had a relative % of proliferating cells of 88.7%，60.5% and 
71.9%, respectively even at 400 |xg/ml. Higher concentration of PTR extracts might 
demonstrate a stronger inhibition, however, PTR extracts were not completely 
soluble in the medium and a very viscous solution with precipitates would be formed 
if the concentration of the extracts was too high. This would greatly hinder the cell 
culture experiments to be carried out effectively. In comparison, CEP and HWE2 
gave a stronger inhibition of which the relative % of proliferating cells was 19.6% 
and 39.8% at 400 ^g/ml, respectively (Table 3.4). 
3.5.4 Effect of PTR extracts on HepG2 cell proliferation 
All the PTR extracts had no inhibitions on HepG2 cells in all tested 
concentrations except in 400 |xg/ml at which the relative % of surviving cells was all 
• higher than 60% (Table 3.5). Therefore, PTR extracts were less effective in exerting 
















































































































































































































































































































































































































































































































































































































































































































































3.5.5 Effect of PTR extracts on normal cell proliferation 
The tumor specificity of the cytotoxic effect of PTR extracts was evaluated 
by two normal cell lines, human Hs68 and monkey Vero. No significant inhibitions 
were found from 12.5 |ag/ml to 400 |^g/ml, suggesting their cytotoxicity was specific 
against cancer cells only (data not shown). This selectivity implicated that the PTR 
extracts might be used as potential antiproliferative agents to cancer cells. 
3.6 Effect of PTR extracts on the proliferation rate of various cell lines in vitro 
Apart from assessing the relative % surviving cells of the cancer cell lines by 
PTR extracts，the proliferation rate of the cells is another specific parameter to 
determine the effectiveness of these potential antitumor agents. The proliferation was 
measured by BrdU incorporation assay which was based on the incorporation of 
pyrimidine analogue, BrdU, into the DNA of proliferating cells during the S phase 
(Roche Applied Sciences, 2003). The relative % proliferating cells of the cancer cell 
« 
lines was examined after 72-hour treatment of PTR extracts in comparison to that of 
control group. Lower percentage of the relative proliferating cells suggested that the 
extract could reduce the proliferation of the cell effectively and had higher 
antiproliferative activity. 
3.6.1 Effect of PTR extracts on HL-60 cell proliferation 
In general, the relative % of proliferating cells decreased with increasing 
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concentrations of PTR extracts applied. All PTR extracts showed significant 
antiproliferative activities on HL-60 cells at 400 |xg/ml, among which HWE2 reduced 
the relative % of proliferating cells the most, up to 7.11%. HWEl, HWE3 and CEP 
demonstrated steady antiproliferative activities from 25 to 100 |ig/ml but the % of 
proliferating cells was reduced to 45.9%, 46.1% and 22.2% by HWEl, HWES and 
CEP at 400 fxg/ml，respectively, indicating their antiproliferative activities were only 
effective at 400 |xg/ml (Fig 3.8). It was clear that the antiproliferative activities of 
other PTR extracts were weaker than HWE2 at 400|a,g/ml and the estimated IC50 
values from the curve were 200|ag/ml for CEP, 400^g/ml for HWEl and HWE2，and 
300 fig/ml for HWES. 
However, a slight proliferative effect was observed in the case of EDP, which 
reflected that it could not reduce the HL-60 cell proliferation effectively (Fig 3.8). 
The antiproliferative activity was regarded as unremarkable because very large 
number of proliferating cells (>70%) still remained up to 400 [ig/ml. 
3.6.2" Effect of PTR extracts on K562 cell proliferation 
< 
Similar antiproliferative effect of PTR extracts on K562 cells was observed at 
all tested concentrations and that they all lowered the relative % of proliferating cells 
the most at 400^g/ml. CEP, HWEl and HWE2 showed significant (p<0.01) 
antiproliferative activities towards K562 cells at 400|ig/ml with a relative % of 
proliferating cells of 22.9%, 15.7% and 6.37% was found, respectively. HWES 
significantly (p<0.01) retarded the proliferation of K562 cells in a dose-dependent 
manner, keeping at about 30% proliferating cells at 400 |ig/ml. EDP showed more 
79 ‘ 
than 50% relative proliferating cells at all tested concentrations, suggesting its 
antiproliferative activity was the least effective among the PTR extracts (Fig 3.9). 
The estimated IC50 values were 300 {ig/ml for CEP and HWEl, 400 [ig/ml for EDP， 
200 \ig/m\ for HWE2 and 100 i^g/ml for HWES. Therefore, it was deduced that 
HWE2 and HWES were more potent in reducing the proliferation of K562 cells than 
HWEl, EDP and CEP. 
3.6.3 Effect of PTR extracts on MCF-7 cell proliferation 
Only HWEl, EDP and CEP lowered the relative % of proliferating cell in 
MCF-7 cells at 200 |xg/ml and 400 jxg/ml, however, their values were higher than 
50% which were regarded as unremarkable results. No antiproliferations were found 
in HWE2 and HWES-treated cells (Table 3.6). To conclude, no substantial 
antiproliferative activities of PTR extracts were observed in MCF-7 cells. 
3.6.4 Effect of PTR extracts on HepG2 cell proliferation 
< 
Similar to MCF-7 cells, the proliferation of HepG2 cells could not be lowered 
by PTR extracts in general. EDP and CEP showed significant (/KO.Ol) inhibition 
only at high concentration (400 |ig/ml), with relative % of proliferating cells of 
31.7% and 17.7%, respectively (Table 3.7). 
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Fig 3.8 The effect of PTR extracts on the proliferation of HL-60 cells determined by 
BrdU incorporation method was expressed as the % proliferating cell against the log 
concentration employed. Different letters represent the significant difference between 
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Fig 3.9 The effect of PTR extracts on the proliferation of K562 cells determined by 
BrdU incorporation method was expressed as the % proliferating cell against the log 
concentration employed. Different letters represent the significant difference between 


























































































































































































































































































































































































































































































































































































































































































3.6.5 Effect of PTR extracts on normal cell proliferation 
The tumor specificity of the antiproliferative activity of PTR extracts was 
examined by the two normal cell lines, human Hs68 and monkey Vero cells. No 
significant changes in relative % of proliferating cells were found from 12.5 fig/ml to 
400 |ig/ml，suggesting that their antiproliferative activities were tumor-selective (data 
not shown). 
3.7 Summary of the cytotoxic and antiproliferative activities exhibited by 
PTR extracts 
A compound is considered to be a potent antitumor agent if it has substantial 
cytotoxic and/or antiproliferative activities specific to tumor cells and not normal 
cells. In the present experiments, both the relative number of surviving cells and 
proliferating cells in treatment group were measured in order to give a more 
comprehensive screening for the effectiveness of PTR extracts. 
PTR extracts possessed different growth inhibitory and antiproliferation 
efficacies towards the four different human cancer cell lines. The retardation of 
growth and proliferation of HL-60 and K562 cells by PTR extracts were more 
significant than those of MCF-7 and HepG2 cells at all tested concentrations. HWE2 
showed the strongest inhibition on HL-60, K562 and MCF-7 cell among the three 
HWEs. CEP was the best PTR extract against MCF-7 cell proliferation but all the 
PTR extracts could not reduce the HepG2 cell proliferation effectively. In general, 
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EDP could not retard the viability and proliferation of all cell lines as effective as 
other PTR extracts. 
HWE2 (approximate LC50 value: 25 ^ig/ml) possessed the strongest 
cytotoxicity while CEP (approximate IC50 value: 200 |ig/ml) had the most potent 
antiproliferative effect on HL-60 cells. Meanwhile, substantial cytotoxicity was 
found in HWE2- and CEP-treated K562 cells while HWE3 (approximate IC50 value: 
100 }xg/ml) reduced the relative % of proliferating K562 cells effectively. Also, 
similar antiproliferative activities exerted by HWE2 retarding the proliferation of 
HL-60 (7.11%) and K562 (6.37%) cells at 400 ^ig/ml were observed. It seemed that 
CEP and HWE2 were the two most promising samples among all the PTR extracts. It 
is interesting that three HWEs exhibited different in vitro cytotoxic and 
antiproliferative efficacies, suggesting HWE2 might have some unique bioactive 
components or favorable chemical structure, such as more expanded conformation as 
mentioned in 3.3，to improve its activity. 
. O n the other hand, it is inevitably that the cell survival and cell proliferation 
‘ of the cancer cells were not completely the same. It was due to the differences in the 
principles, measuring target and specificity of the methods applied. Trypan blue 
exclusion dye method is a simple method that estimates the cell viability by direct 
counting the number of viable cells which has intact membrane to exclude the dye 
(Zhang et al.’ 2004c). MTT method employed in this study measures the cell 
proliferation based on the metabolic activity of the cells to reduce the MTT salt to a 
colored formazan product (Mosmann, 1983). In BrdU incorporation assay, anti-
BrdU-peroxidase (POD) would be bound to the incorporated BrdU during S phase. 
The relative number of proliferating cells was quantified by the light emitted by the 
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reaction product between POD and the substrate solution containing luminol (Roche 
Applied Sciences, 2003). Only a portion of cells was counted in the trypan blue 
exclusion dye method which might increase the measurement errors. In addition, 
MTT method assumes all the cells have the same metabolic activity which also might 
increase the measurement errors. On the contrary, BrdU incorporation assay is an 
ELISA method which would be more specific and is assumed to be more accurate 
than either trypan blue exclusion method or MTT assay. 
HL-60 and K562 cells were more sensitive to the PTR extracts than MCF-7 
and HepG2 cells. Cell cycle-mediated drug resistance has recently reported that the 
sensitivity of a cell to a cytotoxic agent would be affected by the position of the cell 
in the cell cycle or the activation of the cell cycle checkpoint (Schwartz and Shah, 
2005). The efficacy of the agent would be reduced if the treated-cell was arrested at a 
phase which is not the most effective one for the agent. It was thereby hypothesized 
that the difference in the response between the cell lines, such as different cell cycle 
checkpoints elicited, led to different sensitivity to the PTR extracts. Comparing with 
MCF-7 and HepG2 cells, HL-60 and K562 cells might be arrested at a certain phase 
‘ at which PTR extracts were more effective. 
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3.8 Analysis of the effect of PTR extracts on the cell-cycle phases of HL-60 and 
K562 cells 
The in vitro growth inhibitory mechanism(s) of the PTR extracts were 
investigated by the cell cycle distribution of HL-60 and K562 cell lines in terms of 
cell cycle arrest and apoptosis determined by flow cytometry. The approximate IC50 
values of PTR extracts estimated from the BrdU method (3.6) were used to find out 
the effective concentrations which could exert significant effect on cell cycle and 
apoptosis by several trials. Three time points were applied (24 hours, 48 hours, and 
72 hours) in order to observe the trend in the change of cell cycle and apoptosis 
mediated by the PTR extracts. 
Propidium iodide (PI), a fluorochrome that intercalates with DNA molecules, 
can determine the DNA content by flow cytometry. The DNA content in the G2/M 
phase of the cells is doubled to that of the Gi phase. The cells in S phase were 
synthesizing their DNA at the time when they were fixed, the DNA content was 
intermediate between those of the Gi and G2/M phase. DNA fragmentation is typical 
‘ phenomenon in apoptosis so that the DNA content in apoptotic cells was below that 
of the Gi phase (Vermes et al.’ 2000). 
3.8.1 Effect of CEP on cell-cycle phases of HL-60 and K562 cells 
When CEP at 300 |^g/ml was incubated with HL-60 cells, an approximate 3-
fold increment of Sub-Gi (apoptotic) peak was observed in a time-dependent manner 
when compared with the controls (Fig 3.10 and table 3.8). The apoptotic peak was 
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significantly (p<0.01) increased from control of 4.16% cells to 15.5% cells at 72 
hours after CEP treatment. However, there was no significant change in the other 
phases of the cell cycle of the HL-60 cells (Table 3.8). When CEP at 300 |ig/ml was 
incubated with K562 cells, significant increase in the apoptotic peak (20.2%) was 
only observed after 72 hours. There was no significant effect of CEP on the cell 
cycle phases at the three time points, suggesting that CEP could only trigger 
apoptosis in K562 cells after 72 hours (Fig 3.11 and table 3.9). 
In both HL-60 and K562 cell lines, the apoptotic peak was observed without 
any significant changes in each cell-cycle phase，suggesting that apoptosis was 
related to the cytotoxicity of CEP and cell-cycle arrest might not be responsible for 
its triggering. In addition，significant apoptotic peak (2.8-fold of control) was readily 
induced in HL-60 cells upon 24-hour incubation (Table 3.8) while it was only 
observed at 72 hours in K562 cells (1.3-fold of control) (Table 3.9). It might be 
explained by the characteristics of the two cell lines. Overexpression of the 
antiapoptotic Bcl-2 and Bc1-xl was observed in HL-60 and K562 cells, respectively, 
preventing the release of cytochrome c and the initiation of apoptosis (Martins et al” 
‘ 1997). Nevertheless, HL-60 was known to be apoptotic-proficient that can induce 
apoptosis when it was treated with various chemotherapeutic drugs (Cao et al., 2004). 
In opposite, K562 was an apoptotic-resistant cell lines that many chemotherapeutic 
drugs were not effective enough to eliminate it. It is because it contains the 
Philadelphia chromosome expressing the bcr-abl protein, resulted from a reciprocal 
translocation that the abl gene on chromosome 9 is transferred to chromosome 22 
that includes the bcr gene (Yassin et al., 2003). The bcr-abl protein in K562 cells was 
thought to be the main reason for their resistance to apoptosis (Yassin et al.，2003). 
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Delayed apoptosis in K562 cells after exposure to other agents has been 
reported. An antimitotic agent, docetaxel, at 10' M induced DNA fragmentation in 
HL-60 cells less than 6 hours and apoptotic bodies was observed at 24 hours, while 
apoptotic characteristics of K562 cells became obvious at 48 hours and DNA 
fragmentation was evident at 24 hours (Cao et al., 2004). Using a DNA-damaging 
agent, etoposide at 10 |a,M, 35% and 90% apoptotic cells were detected in treated-
HL-60 cells at 6 hours and 24 hours, respectively, but no significant apoptotic cells 
was observed in K562 cells at both time points. DNA fragmentation was only 
observed when K562 cells were treated with 100 jxM of etoposide for 24 hours (Ritke 
et al” 1994). Therefore, the delayed apoptotic induction in K562-treated cells with 
lower extent might be due to the presence of bcr-abl protein to allow the cells to have 
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Fig. 3.10 Representative cytograms showing the effect of CEP at 300 昭/ml on the 
cell-cycle phases (Gq/Gi, S, and G2/M) and apoptosis (Sub-G 1 peak) of HL-60 cells at 
24，48 and 72 hours. 
Table 3.8 Numeric expression of the relative cell number on the cell-cycle phases and 
apoptosis of HL-60 cells by CEP at 300 \ig/ml 
« 
Group % Apoptotic cells % Non-apoptotic cells 
(Sub-GI) Gq/Gi I S Gz/M “ 
24h control 2.90士0.36 39.2士0.4249.7士0.31 11.2士0.12~ 
24h CEP 8.04土 1.19# 41.2士 1.29 49.1土 1.89 9.77士0.60 
48h control 3.91 士 1.52 44.5士2.2345.2士2.20 10.3士0.35 
48h CEP 8.95士 1.03 # 44.7士 1.13 44.7士0.84 10.6士0.26 
72h control 4.16士0.70 44.8土 1.30"“45.8士 1.00 9.37士0.45~ 
72h CEP 15.5士2.69# | 42.4士 1.97 | 47.8士 1.34 9.80±1.73 
Different letters represent the significant difference between the relative number of 
cells in control group and treatment group by Student's t-test (* p< 0.05, # ;?< 0.01 
and @p< 0.001). 
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Fig. 3.11 Representative cytograms showing the effect of CEP at 300 ^ig/ml on the 
cell-cycle phases (Gq/Gi, S, and Gj/M) and apoptosis (Sub-Gi peak) of K562 cells at 
24, 48 and 72 hours. 
Table 3.9 Numeric expression of the relative cell number on the cell-cycle phases and 
apoptosis of K562 cells by CEP at 300 ng/ml. 
i 
Group % Apoptotic cells % Non-apoptotic cells 
(Sub-GI) Gq/Gi | S I Gz/M 
24h control 15.1 士3.24 31.0士2.9753.8士0.71 15.3士2.33 
24h CEP 14.9士2.93 29.7士0.21 54.1 士 1.84 16.2士 1.56 
48h control 16.4士2.18 28.9士2.47 52.5土 1.84 18.7士0.49~ 
48h CEP 16.9士 1.56 31.2士0.64 52.7士 1.48 16.2士0.85 
72h control 16.2士3.78 30.8士 1 .4150.4士0.71 18.8士2.19~ 
72h CEP 20.2士 1.90* | 28.6士0.35 | 52.4士0.14 19.1 士0.57 
Different letters represent the significant difference between the relative number of 
cells in control group and treatment group by Student's t-test (* p< 0.05, # ;?< 0.01 
and @p< 0.001). 
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3.8.3 Effect of HWEl on cell-cycle phases of HL-60 and K562 cells 
EDP at 400 ng/ml induced apoptosis but not necrosis in HL-60 cells at the 
three time points and the apoptotic peak was the most prominent at 72 hours (Fig. 
3.12 and table 3.10). Besides, an accumulation of cells at the G2/M phase which 
accounted for 16.3% was observed after 24 hr-incubation, significantly (p<0.05) 
higher than the 11.9% found in control group (Table 3.10). Halting the cells at 
particular phase of the cell cycle might give time for the cell to repair the damaged 
DNA whereas apoptosis might eliminate the damaged cells that could not be repaired 
(Lu et al, 2006). It was thereby hypothesized that apart from apoptosis, EDP might 
arrest cells at the G2/M phase after 24 hour-incubation to lower the proliferation rate 
of HL-60 by delaying the entry of the cells into mitosis. When 400 |xg/ml of EDP 
was incubated with K562 cells，significant apoptotic peak was also observed and no 
necrosis was obtained at three time points (Fig. 3.13 and table 3.11). However, the 
ratio of the apoptosis between the control and treatment group was slightly decreased 
(5.88 for 24 hours, 4.53 for 48 hours and 4.45 for 72 hours) (Table 3.11). As the ratio 
is directly affected by the precision of control, further analysis is required for this 
survival shift. 
V 
Clearly, the growth inhibition exhibited by EDP on the HL-60 cells was 
mainly due to apoptosis and partly due to G2/M arrest, whereas the growth of K562 
cells was inhibited by EDP mainly via apoptosis. Higher % apoptosis was found in 
HL-60-treated cells than K562-treated ones, suggesting that HL-60 cells was more 
sensitive to EDP treatment than K562 cells, consistent with the cytotoxic analyses 
previously (3.5.2 and 3.6.2). 
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Fig. 3.12 Representative cytograms showing the effect of EDP at 400 |ig/ml on the 
cell-cycle phases (Gq/Gi, S, and G2/M) and apoptosis (Sub-Gi peak) of HL-60 cells at 
24, 48 and 72 hours. 
Table 3.10 Numeric expression of the relative cell number on the cell-cycle phases 
and apoptosis of HL-60 cells by EDP at 400 |ig/ml. 
Group ®/o Apoptotic cells % Non-apoptotic cells 
(Sub -GI) GQ/GI | S I G2/M 
24h control 5.30±1.85 42.3士9.2245.8土 11.7 11.9士2.64~ 
24h EDP 41.8士4.03 # 41.1 土3.16 42.7士3.35 16.3士2.89* 
48h control 6.64士1.56 38.9士3.2747.2士2.23 14.0士2.41 ~ 
48h EDP 44.3士8.77 # 38.9士3.96 47.9士0.81 13.3士0.72 
72h control 6.60士0.65 40.6士0.95 46.8士0.50 12.6±1.70~ 
72h EDP 48.8土4.10# | 38.0土2.25 | 48.3士0.55 13.7士0.57 
Different letters represent the significant difference between the relative number of 
cells in control group and treatment group by Student's t-test {* p< 0.05, # p< 0.01 
and @p< 0.001). 
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Fig. 3.13 Representative cytograms showing the effect of EDP at 400 |ig/ml on the 
cell-cycle phases (Gq/G i, S，and G2/M) and apoptosis (Sub-G 1 peak) of K562 cells at 
24,48 and 72 hours. 
Table 3.11 Numeric expression of the relative cell number on the cell-cycle phases 
< 
and apoptosis of K562 cells by EDP at 400 |ig/ml. 
v 
Group % Apoptotic cells % Non-apoptotic cells 
(Sub-Gi) Gq/Gi I S G2/M 
24h control 6.78±1.50 26.5士 1.50""“52.7±1.58 20.8士2.25~ 
24h EDP 39.9士4.47 # 28.0士2.31 51.8土2.11 20.2士2.35 
48h control 6.34士 1.22 27.8士 1.25 59.9士4.54 12.4士5.52~ 
48h EDP 28.7士6.59 # 26.6士0.87 58.3士2.36 15.1 士2.04 
72h control 5.59士 1.37 18.3士4.4664.4士2.78 17.2士 1 . 6 7 ~ 
72h EDP 24.9士 1.62® | 26.2士3.10 | 58.5士2.13 * | 15.3士 1.91 
Different letters represent the significant difference between the relative number of 
cells in control group and treatment group by Student's t-test (* p< 0.05, # ;?< 0.01 
and @p< 0.001). 
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3.8.3 Effect of HWEl on cell-cycle phases of HL-60 and K562 cells 
When HL-60 cells were incubated with HWEl at 400 |ig/ml, a significant 
(p<0.05) apoptotic peak was observed at the 48 hours and 72 hours when compared 
with the control (4.4% and 12.6%, respectively). The apoptotic peak at 72-hour 
incubation was increased to approximately 6-fold of the control (Table 3.12). 
Besides, it could be clearly seen that the cells were significantly accumulated at the S 
phase in the treatment groups, while the number of cells in the Gq/Gi phase was 
concomitantly smaller. From 48 to 72 hours, the percentage of the G2/M phase cells 
was also decreased, reflecting that fewer number of cells progressed into the G2/M 
phase in the treatment group (Fig 3.14 and table 3.12), speculating that those arrested 
cells might shift to apoptosis. 
When 300 |j,g/ml of HWEl was incubated with K562 cells, a significant 
(p<0.05) accumulation of the S-phase cells was observed at 24 hours, followed by 
the occurrence of a significant (p<0.05) apoptotic peak of 27.2% and 33.3% at 48 
hours and 72 hours, respectively (Fig 3.15 and table 3.13). It was hypothesized that 
the accumulated S-phase cells might shift to apoptosis due to prolonged arrest, or 
i 
apoptosis was also triggered during a longer treatment time (48 hours). 
V 
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Fig. 3.14 Representative cytograms showing the effect of HWEl at 400 |xg/ml on the 
cell-cycle phases ( G q / G i , S, and G2/M) and apoptosis (Sub-GI peak) of HL-60 cells at 
24, 48 and 72 hours. 
Table 3.12 Numeric expression of the relative cell number on the cell-cycle phases 
' and apoptosis of HL-60 cells by HWEl at 400 ng/ml. 
Group % Apoptotic cells % Non-apoptotic cells 
(Sub-Gi) GQ/GI | S I G2/M 
24h control 2.3士0.7 43.5士0.4 43.6士0.6 16 .7±0.5~ 
24h HWEl 3.9士0.2 33.7士0.5# 49.3士 1.1 # 17.1 士0.6 
48h control 2.4士0.1 45.2士0.6 40.0士0.5 14.9士0.1 
48h HWEl 4.4士0.2 # 39.3士0.6* 43.0±1.6 17.7士0.9 
72h control 2.9士0.3 42.8士 1.3 40.4士 1.0 16.9士0.4~ 
72h HWEl 12.6土2.0* 39.6士0.4 45.6土0.7* 14.9士 1.0 
Different letters represent the significant difference between the relative number of 
cells in control group and treatment group by Student's t-test (* p< 0.05, # ;?< 0.01 
and @p< 0.001). 
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Fig. 3.15 Representative cytograms showing the effect of HWEl at 300 jig/ml on the 
cell-cycle phases ( G q / G i , S, and G2/M) and apoptosis (Sub-G 1 peak) of K562 cells at 
24，48 and 72 hours. 
^ Table 3.13 Numeric expression of the relative cell number on the cell-cycle phases 
and apoptosis of K562 cells by HWEl at 300 |ig/ml. 
Group % Apoptotic cells % Non-apoptotic cells 
(Sub-GI) G q / G i | S I G z / M 
24h control 15.1±3.24 31.0士2.9753.8士0.71 15.3士2.33 
24h HWEl 14.1 士 1.27 24.5士3.54 59.5土2.47* 16.1 士 1.06 
48h control 16.4士2.18 28.9士2.47 52.5士 1.84 18.7±0.49 
48h HWEl 27.2士0.02* 29.9土 1.27 54.7土0.14 15.4士 1.13 
72h control 16.2士3.78 30.8士 1.4150.4土0.71 18.8士2.19 
72h HWEl 33.1 士6.34* 24.8士7.00 50.2士3.35 15.2士0.13 
Different letters represent the significant difference between the relative number of 
cells in control group and treatment group by Student's t-test (* p< 0.05, # ;?< 0.01 
and @p< 0.001). 
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3.8.3 Effect of HWEl on cell-cycle phases of HL-60 and K562 cells 
HWE2 (200 ^ig/ml)- treated HL60 cells were accumulated at S phase at 24 
hours and 48 hours, however, it was decreased to 37.1% with a concomitant increase 
in the percentage of cell at Gq/G i phase (Table 3.14). The apoptotic peak was 
increased significantly (p<0.05) from 8.18% in the control to 14.5% in the treatment 
group at 48 hours. At 72 hours, it was significantly (p<0.001) increased from 5.96% 
in the control to 68.1% in the treatment group (Fig 3.17 and table 3.14). No necrosis 
was observed at three time points (Fig 3.17). Similar result was also obtained by 
annexin-V/PI staining assay, showing 4.4-fold of early apoptosis and 3.5-fold of late 
apoptosis when compared with control (Fig. 3.16). One of the hypotheses was that 
HWE2 might cause S arrest at 24 and 48 hours and Gi arrest was initiated only at 72 
hours. Another one was HWE2 might only cause S arrest and those cells arrested at S 
phase was shifted to apoptosis at 72 hours so that most cells were found in the peak 
of Gq/G i phase (Table 3.14). As a result, a high percentage of cells had undergone 
apoptosis that eliminated the HL-60 cells effectively. 
In contrast, HWE2 at 200 |xg/ml could not increase the % of K562 cells in the 
apoptotic peak at all three tested time points. However, increment of the % of cells in 
S phase was found, which was negatively correlated with the decrease of the % of 
Gq/Gi phase cells -0.9877). The % of cells in the Gi phase was lowered 
significantly from 16.5% in the control to 12.1% in the treatment group at 48 hours, 
consistent with the elevated % of cells in the S phase. However, at 72 hours, no 
significant reduction of G2 phase cells was observed, implying that some cells in the 
S phase had shifted to G2 phase (Fig 3.18 and table 3.15). Longer incubation time 
should be carried out to determine whether the S-phase cells had escaped from the 
98 
arrest or G2/M arrest was also begun to initiate. 
It could be seen that apoptosis was only induced in the apoptosis-proficient 
HL-60 cells but not in the apoptosis-resistant K562 cells by HWE2. Elevation of 
cells in the S phase was observed in both cell lines, but further analysis should be 
carried out. 
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Fig. 3.16 Bivariate Pl/annexin V analysis of the (a) untreated and (b) PTR HWE2-
treated (200 |ag/ml) HL-60 cells 
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Fig. 3.17 Representative cytograms showing the effect of HWE2 at 200 |xg/ml on the 
cell-cycle phases ( G q / G i , S, and G2/M) and apoptosis (Sub-GI peak) of HL-60 cells at 
24,48 and 72 hours. 
Table 3.14 Numeric expression of the relative cell number on the cell-cycle phases 
i 
and apoptosis of HL-60 cells by HWE2 at 200 jxg/ml. 
V 
Group % Apoptotic cells % Non-apoptotic cells 
(Sub-GI) G q / G i | S G q / G i 
24h control 10.9士2.72 40.9士 1.56 41.1 士2.55 18.0±0.54 
24h HWE2 15.7士5.30 43.0士3.37 44.8士 1.45 12.2士2.63 
48h control 8.18±1.85 42.6士2.00 44.7士0.61 12.7士 1.41 
48h HWE2 14.5士0.81* 40.3土2.10 49.2士 1.48* 12.2士0.99 
72h control 5.96士2.82 38.0士1.31 48.1 士0.35 13.9士 1.66 
72h HWE2 68.1士4.20® | 53.6士2.11 ® | 37.1 士3.40# | 9.4士3.17 
Different letters represent the significant difference between the relative number of 
cells in control group and treatment group by Student's t-test (* p< 0.05, # ;?< 0.01 
and @p< 0.001). 
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Fig. 3.18 Representative cytograms showing the effect of HWE2 at 200 |xg/ml on the 
cell-cycle phases (Gq/Gi, S, and G2/M) and apoptosis (Sub-G 1 peak) of K562 cells at 
24,48 and 72 hours. 
Table 3.15 Numeric expression of the relative cell number on the cell-cycle phases 
and apoptosis ofK562 cells by HWE2 at 200 \ig/ml 
Group Apoptotic cells Non-apoptotic cells 
(Sub-GQ G q / G i S G2/M 
24h control 1 0 . 2士 0 . 4 0 2 8 . 5 ± 5 . 2 7 5 3 . 1 土 2 . 1 5 18.4士 1 . 6 9 
24h HWE2 10.7土0.49 24.9士4.21 55.4士3.62 19.6士 1.47 
48h control 8.94士0.52 30.1士3.85 53.4士2.45 1 6 . 5 ± 1 . 9 9 
48h HWE2 9.95士 1.78 28.3士4.23 59.5士0.87* 12.1 士 1.60* 
72h control 8.00±0.88 30.3士2.88 56.1士 1.66 13.6士3.62 
72h HWE2 8.29士2.51 21.7士3.40* 65.2土2.58# 13.1 士4.87 
Different letters represent the significant difference between the relative number of 
拿 a 
cells in control group and treatment group by Student's t-test ( p< 0.05，p< 0.01 
and 0.001). 
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3.8.3 Effect of HWEl on cell-cycle phases of HL-60 and K562 cells 
When HWES at 200 |xg/ml was incubated with HL-60 cells, significant 
(p<0.05) increases of apoptotic peak and S-phase peak were observed at all three 
time points, having 60.0% and 51% cells in the Sub-Gi peak and S peak at 72 hours, 
respectively (Table 3.16). On the other hand, similar ratio from control to treatment 
group was observed in the cell cycle of non-apoptotic HL-60 throughout the three 
time points (0.8 for Gq/G i phase, 1.2 for S phase and 0.8 for G2/M phase) (Fig 3.19 
and table 3.16). Thus, the effect of HWES on the cell cycle of HL-60 cells could not 
be enhanced by longer treatment time. HWE3 at 100 |ig/ml caused no significant 
changes in the cell cycle of K562 cells though an increase of the % of the cells in S 
phase was observed (Table 3.17). Apoptotic peak was significantly (p<0.05) 
increased (Fig. 3.20) but the ratio of the apoptotic cells in treatment group to control 
group was slightly decreased from 24 hours to 72 hours (2.1 for 24 hours, 1.4 for 48 
hours, 1.3 for 72 hours), implying the rate to trigger apoptosis might be decreasing. 
As same as EDP-treated HL-60 cells, it might be due to the deviations between the 
control groups and therefore further investigation is still required for this 
‘ phenomenon (Fig 3.20 and table 3.16). 
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Fig. 3.19 Representative cytograms showing the effect of HWES at 200 |xg/ml on the 
cell-cycle phases (GQ/GI, S, and G2/M) and apoptosis (Sub-GI peak) of HL-60 cells at 
24, 48 and 72 hours. 
Table 3.16 Numeric expression of the relative cell number on the cell-cycle phases 
and apoptosis of HL-60 cells by HWE3 at 200 ng/ml. 
Group % Apoptotic cells % Non-apoptotic cells 
(Sub -GI) GQ/GI | S G2/M 
24h control 1.8士0.5 43.2土1.0 43.1 士0.8 13.8士0.2 
24h HWE3 47.6士3.7* 38.4士0.4* 50.5士2.1* 11.2士0.7 
48h control 2.2士0.9 42.3士0.7 44.0士0.2 13.8士0.9 
48h HWE3 47.4士7.3 * 37.9士 1.9 50.8士3.0 11.4士 1.2 
72b control 2.0士0.04 42.4士0.4 43.6±0.3 14.1 士0.6 
72h HWE3 60.0土 1.3* 37.1 士2.0 51.0^2.4* 11.9士0.4* 
Different letters represent the significant difference between the relative number of 
* a 
cells in control group and treatment group by Student's t-test ( p< 0.05, p< 0.01 
and 0.001). 
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Fig. 3.20 Representative cytograms showing the effect of HWE3 at 100 jig/ml on the 
cell-cycle phases (GQ/GI, S, and G2/M) and apoptosis (Sub-GI peak) of K562 cells at 
24，48 and 72 hours. 
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Table 3.17 Numeric expression of the relative cell number on the cell-cycle phases 
� and apoptosis of K562 cells by HWE3 at 100 ^ig/ml. 
Group % Apoptotic cells % Non-apoptotic cells 
(Sub-GI) G q / G i I S G2/M “ 
24h control 11.8士0.74 25.4士2.86 53.9±3.0920.7士0.58 
24h HWE3 24.7土 1.68® 25.5土2.60 53.2土3.44 21.4士3.75 
48h control 17.7士0.21 2 5 . 5士 1.47 5 3 . 7士 1 . 6 3 20.9士0.61 
48h HWE3 24.8士3.24* 23.0士 1.59 55.2士 1.68 22.0士4.40 
72h control 17.5±1.61 27.2士 1.79 50士 1.50 17.0±2.72 
72h HWE3 22.7土0.91* 27.0士3.34 55.7土0.2 17.4士3.25 
Different letters represent the significant difference between the relative number of 
)|i n 
cells in control group and treatment group by Student's t-test ( p< 0.05, p< 0.01 
and ® p< 0.001). 
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3.8.6 Summary 
The PTR extracts triggered apoptosis and/or caused cell-cycle arrest in HL-60 
and K562 cells as revealed by the above results from the flow cytometry. Different 
responses to the PTR extracts might be due to different cell types and their sensitivity 
and the resistance to the extracts. Apoptosis was readily observed in HL-60 cells 
incubated with the PTR extracts, however, K562 cells were shown to be resistant to 
apoptosis when incubating with 200 jig/ml of HWE2 and delayed apoptosis occurred 
in response to 300 |ig/ml of HWEl and CEP. It is believed to be related to the 
characteristics of these two cell lines as it has been reported that different cancer cell 
lines would give different responses to the antitumor agents (Jiang et al., 2004). 
Besides, the concentration of the PTR extracts employed in the flow cytometric 
analysis was the IC50 value estimated from the BrdU incorporation assay, thus there 
were inevitably slight deviations between the results from the two assays that the % 
apoptosis from flow cytometry might not be 50%. Since apoptosis-proficient HL-60 
cells was more sensitive to PTR treatment, HL-60 cell line was chosen to further 
study on the expression level of cellular proteins. Among three PTR HWEs, HWE2 
seemed to be the most promising one that induce S arrest and apoptosis in HL-60 
t 
cells. The cellular proteins involved in its S arrest and apoptosis were also further 
investigated by western blot. 
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3.9 The effect of PTR extracts on expression of cellular proteins involved in 
cell-cycle control and apoptotic pathway in HL-60 cells 
The cellular proteins attributed in the pathways of cell-cycle arrest and 
apoptosis in HL-60 cells treated with PTR extracts were investigated by western blot 
in order to gain insights on their mechanisms. The expression levels of proteins were 
semi-quantified by densitometer. 
3.9.1 Expression of Bcl-2 and Bax proteins in HL-60 cells treated with PTR 
extracts 
Bcl-2 family proteins are key regulators in apoptosis, particularly the 
antiapoptotic Bcl-2 and proapoptotic Bax proteins (Oltvai et al, 1993). Bcl-2 locates 
in the outer mitochondrial membrane to inhibit the release of cytochrome c, while 
Bax is activated to antagonize the effect of antiapoptotic proteins and directly 
disrupts the mitochondrial membrane (Cory and Adams, 2002). Bax/Bcl-2 ratio 
determines the susceptibility of cells to apoptosis and the therapeutic response to the 
chemotherapy (Raisova et al, 2001). Their expressions which were affected by PTR 
extracts were investigated to see whether they are responsible for the respective 
apoptotic induction. 
The expression of Bcl-2 protein in HL-60 cells was lowered in a time-
dependent manner after CEP (Fig 3.21a) and HWE3 (Fig 3.25a) treatment, whereas 
that of Bax protein was increased greatly after 72-hour incubation in CEP and HWES 
treatments. Also, the increase in the apoptosis was negatively correlated with the 
increase in the Bax/Bcl-2 ratio and which was the highest increase at 72 hours (Fig 
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3.21b and 3.25b), consistent with the highest percentage of apoptosis observed in 
flow cytometry (Fig 3.10 and table 3.8; Fig 3.19 and table 3.16). EDP also 
unregulated the expression of Bax protein in a time-dependent manner and Bcl-2 
protein expression was reduced evidently (Fig 3.22a). The trend of Bax/Bcl-2 ratio 
obtained in EDP-treated HL-60 cells at the three time points (Fig 3.22b) was 
consistent with that of apoptosis found from flow cytometry (Fig 3.12 and table 3.10). 
These PTR extracts were similar to Grifolan isolated from the fruiting bodies of 
Albatrellus confluens that inhibited the human nasopharyngeal carcinoma CNEl in 
vitro by apoptosis involving downregulation of Bcl-2 and upregulation of Bax with a 
concomitant increase ofBax/Bcl-2 ratio (Ye et al.’ 2005). 
The expression of Bcl-2 protein was not modulated by HWEl but the Bax 
was unregulated at 48 and 72 hours (Fig 3.23a), so the Bax/Bcl-2 ratio of the HWEl-
treated HL-60 cells was increased in a time-dependent fashion that shifted the cells 
into apoptotic death (Fig 3.23b). In HWE2-treated cells, the expression level of the 
Bax protein was markedly increased at three time points while that of Bcl-2 protein 
was reduced in a time-dependent manner (Fig 3.24a). It seemed that the expression 
* level of Bcl-2 protein might be a determining factor for triggering of apoptosis as the 
percentage of apoptosis (68.1%) was sharply increased when the Bcl-2 protein 
expression was the lowest at 72 hours. However, the Bax/Bcl-2 ratio was not reduced 
time-dependently as expected from the flow cytometric analysis (Fig 3.24b). This 
might due some deviations occurred in western blot and hence more repeats should 
be done to make a better quantification. 
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[ • C t r l DCEP-treated cells | 
‘ Fig. 3.21 (a) The Bcl-2 and Bax expressions in HL-60 cells incubated with CEP at 
‘ 300 |xg/ml for 24, 48 and 72 h with the relative density of the band measured by 
“ densitometer, p -actin was used as the loading control, (b) The corresponding ratio of 
the relative density ofBax/Bcl-2 in CEP-treated HL-60 cells. 
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Fig. 3.22 (a) The Cdkl, Bcl-2 and Bax expressions in HL-60 cells incubated with 
EDP at 400 |xg/ml for 24, 48 and 72 h with the relative density of the band measured 
by densitometer, p -actin was used as the loading control, (b) The corresponding ratio 
of the relative density of Bax/Bcl-2 in EDP-treated HL-60 cells. 
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Fig. 3.23(a) The Bcl-2 and Bax expressions in HL-60 cells incubated with HWEl at 
400 i^g/ml for 24，48 and 72 h with the relative density of the band measured by 
densitometer, p -actin was used as the loading control, (b) The corresponding ratio of 
the relative density of Bax/Bcl-2 in HWEl-treated HL-60 cells. 
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Fig. 3.24(a) The cyclin E, Cdk2, Bcl-2 and Bax expressions in HL-60 cells incubated 
� 
with HWE2 at 200 |ig/ml for 24，48 and 72 h with the relative density of the band 
measured by densitometer, p -actin was used as the loading control, (b) The 
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Fig. 3.25(a) The Bcl-2 and Bax expressions in HL-60 cells incubated with HWE3 at 
200 |ig/ml for 24，48 and 72 h with the relative density of the band measured by 
densitometer, p -actin was used as the loading control, (b) The corresponding ratio of 
the relative density ofBax/Bcl-2 in HWE3-treated HL-60 cells. 
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3.9.2 Expression of cyclins and Cdks in HL-60 cells by PTR extracts 
Cyclin B/Cdkl complex is important in the G2/M transition and it is only 
activated when mitosis is ready to begin (Schwartz & Shah, 2005). The cell could not 
progress normally if either one of these protein levels was lowered. The expression 
of Cdkl was downregulated by EDP at 24 hours only (Fig 3.22c), consistent with the 
accumulation of cells in G2/M peak found in flow cytometry (Fig 3.12 and table 
3.10). The G2/M arrest had possibly occurred which was due to the limited supply of 
cdkl, similar to the squamocin-induced G2/M arrest in K562 cells that decreased the 
protein level of Cdkl and the subsequent formation of cyclin Bl/Cdkl complex even 
the cyclin B1 expression was not changed (Lu et al, 2006). Besides, the inhibition of 
Ganoderma lucidum extract on PCS prostate cancer cells was via G2/M arrest by 
lowering the expression of Cdkl and cyclin B (Jiang et al,, 2004). Further 
investigation should be performed to understand the whole mechanism, for instance, 
the action of EDP might be similar to other natural Cdk inhibitors, such as p21, that 
inhibit the Cdk activation directly or target its upstream pathway that regulates its 
activity (Schwartz and Shah, 2005). 
V-
The expression of cyclin E was enhanced by HWE2 (Fig 3.24c)，similar to 
the PSP isolated from Coriolus versicolor induced S arrest in HL-60 cells via an 
upregulation of cyclin E reported previously (Hui et al” 2005). Moreover, the 
possibility that Gi arrest occurred at 72 hours could be ruled out as cyclin E was 
upregulated at three time points. Cyclin D and cyclin E expressions should be 
reduced when Gi arrest so that pRb protein could not be phosphorylated and cells 
were arrest at the Gi phase. For instance, Hypsizigus marmoreus induced Gi arrest in 
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HepG2 cells by lowering the expression of cyclin D1 and E (Chang et al, 2004); the 
carboxymethylated P-glucan isolated from PTR sclerotium inhibited the proliferation 
of MCF-7 cell via Gil arrest by down-regulating cyclin D1 and cyclin E expressions 
(Zhang et al., 2006a). 
Besides, Cdk2 expression level was lowered by HWE2 (Fig 3.24d). 
Inactivation of Cdk2 could block the loading of CDC45 onto DNA. DNA polymerase 
would not be recruited and so no DNA replication was initiated (Kastan and Bartek, 
2004). Therefore, cells would be halted at the S phase. Cdk2 could form complex 
with cyclin E and cyclin A which are responsible for Gi/S transition and S phase 
progression, respectively. Based on the result of flow cytometry and cyclin E 
expression，Cdk2 might be inactivated after the cell has already passed through the 
Gi/S boundary. The function of CDC 45 was then affected and the S phase 
progression might be hindered due to the inhibited activity of cyclin A/Cdk2 
complex. Further investigations are required to find out time that Cdk2 is inactivated 
to support this hypothesis. 
‘ In summary, the inactivation of Cdk2 and upregulated cyclin E might be 
� associated with the S arrest in the HL-60 cells caused by HWE2. After considering 
the cytogram of HWE2-treated HL-60 cells, the highest percentage of cells observed 
in Gi phase might be due to the cells in S and G2/M phases might shift to apoptosis 
after long incubation period. There was relatively smaller amount of cells in these 
phases, leading to an increase in the numeric expression of cells found in Gi phase. 
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3.9.3 The plausible antiproliferative mechanism(s) involved in PTR extracts on 
HL-60 cells 
It has been realized that tumor growth was an equilibrium between cell 
proliferation and cell death. Therefore, delaying the proliferation rate and promoting 
apoptosis in cancer cells would be an effective strategy in cancer treatment. PTR 
extracts had been revealed that they could modulate the protein expressions 
contributed in the pathways of cell cycle arrest and apoptosis. 
Although HL-60 cells lost the p53 tumor suppressor protein, PTR extracts 
still induced apoptosis via the upregulation of its downstream product, Bax protein. It 
was thereby revealed that the upregulation of the Bax level by PTR extracts to 
promote apoptosis in the HL-60 cells was through a p53-independent pathway. It is 
well known that Bcl-2 and Bax are involved in the intrinsic mitochondrial-dependent 
pathway. Bax protein neutralizes the anti-apoptotic effect of Bcl-2 protein and 
increases the mitochondrial membrane permeability, leading to the release of 
cytochrome c. It would further bind to Apaf-1 and caspase 9 to form apoptosome. 
The caspase 9 would cleave and activate the effector caspase 3, a series of apoptotic 
‘ changes was then triggered (Cory and Adam, 2002; Okada and Mak, 2004). Although 
the pathway mediated by the PTR extracts in HL-60 cells was not fully understood 
from the present results, it was suggested that the apoptosis induced by the PTR 
extracts was associated with the augment of Bax/Bcl-2 ratio and might be partially 
controlled by the mitochondrial-dependent pathway. 
The fact that the PTR extracts could induce S or G2/M arrest, instead of Gi 
arrest, in HL-60 cells might be due to the lack of functional p53 protein in HL-60 
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cells. Gi arrest is solely regulated by the tumor suppressor proteins p53 and pRb 
(Murray, 2004). It has been reported that cells with p53 are usually arrested at the Gi 
phase whereas those that lack p53 would preferentially be arrested at the S and G2/M 
phases (Eastman, 2004). For instance, an alkaline-soluble p-glucan extracted from 
the mycelium of Poria cocos was reported to have antiproliferative activity MCF-7 
cells which has an intact p53 protein. It was also found that this p-glucan caused cell-
cycle arrest at Gi phase and apoptotic induction, revealed by western blot showing 
that cyclin D1 and E expressions were reduced whereas Bax/Bcl-2 ratio was elevated 
(Zhang et al, 2006b). PSP (25 |ig/ml) isolated from Coriolus versicolor mycelia 
could arrest the HL-60 cells at the S and G2/M phases with elevation of cyclin E 
expression (Hui et al, 2005). Recently, many mushroom polysaccharides showed in 
vitro antiproliferative effect by cell cycle arrest and apoptosis. Ganoderma lucidum 
extract, containing polysaccharides and triterpenes, inhibited the growth of PC3 
prostate cancer cells by G2/M arrest to halt its cell cycle (Jiang et al” 2004). Protein-
bound polysaccharides (PL) isolated from Phellinus linteus inhibited the growth of 
SW480 human colon cancer cells significantly via G2/M arrest and apoptosis, which 
were associated with the decrease of the Bcl-2 level and an increase in the 
‘ cytochrome c level which promoted the occurrence of apoptosis and a decrease of 
‘ cyclin B1 expression so as to delay the G2 to M phase progression (Li et al, 2004). 
Besides, the carboxymethylated p-glucan isolated from PTR sclerotium was 
shown to exhibit antiproliferative activity towards MCF-7 cells via Gi arrest and 
apoptotic induction by depletion of cyclin D1 and cyclin E expressions and lowering 
Bcl-2 expression to increase the Bax/Bcl-2 ratio, respectively (Zhang et al,，2006a). 
This suggested that the polysaccharides isolated from various developmental stage of 
PTR could exert in vitro antiproliferative activity against HL-60 and MCF-7 cells by 
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cell cycle arrest and/or apoptotic induction. It is likely that their mode of action was 




Chapter 4 CONCLUSIONS AND FUTURE WORKS 
4.1 Conclusions 
Aqueous extracts from the different morphological forms of PTR varied 
greatly not only in their chemical composition but also their potency and mechanism 
of antiproliferative activities. CEP and EDP were high in carbohydrate content 
(83.4% and 87.2%, respectively) and low in protein content (15.9% and 3.24%, 
respectively). In contrast, three HWEs had comparatively higher protein content 
(>30.4%) but lower carbohydrate content. Mannose was dominant in CEP while 
glucose was the major monosaccharides in the EDP and HWEs. Besides, the amount 
of mannose and galactose were substantial in the HWEs. HWEs had a higher 
molecular weight (above 156 x lO*) than CEP and EDP (MW of 4.4 x lO"^  and 50.9 x 
10^ respectively). 
The present study was the first one to demonstrate that CEP, which was 
suggested to be a mannan according to the previous results (Wong, 2004), reduced 
^ the viability and rate of proliferation of HL-60 cells significantly (p<0.05) via 
� apoptosis involving downregulation of Bcl-2 and upregulation of Bax with a 
concomitant increase of Bax/Bcl-2 ratio. Moreover, EDP, probably a glucan as 
previously described (Wong, 2004), caused a G2/M arrest and induced apoptosis in 
the HL-60 cells, which might be correlated with the reduced Cdkl and Bcl-2 
expressions, as well as augmented expression of Bax and the Bax/Bcl-2 ratio. This 
was different from our previous study of a (1—3)-|3-glucan obtained from Poria 
cocos mycelium which was found to inhibit the proliferation of MCF-7 cancer cells 
by Gi arrest and apoptotic induction via downregulating anti-apoptotic protein Bcl-2 
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(Zheng et al., 2006). Also, the water-soluble carboxymethylated (l-^3)-p-glucans 
obtained from sclerotia of PTR had been shown to inhibit the proliferation of MCF-7 
cell via Gi arrest by downregulating cyclin Dl and cyclin E expressions and 
apoptotic induction by lowering Bcl-2 expression and increasing the Bax/Bcl-2 ratio 
(Zhang et al., 2006a). The above different observations might be due to the 
difference in the cell lines used as MCF-7 cell was p53-positive while HL-60 cell 
was p53-defective. Previous findings have revealed that cells that are lack of p53 
protein preferentially arrested at S and G2/M phases but cells with functional p53 
would usually have Gi arrest (Eastman, 2004). Also, other factors such as molecular 
weight, conformation and linkage between the glucose residues would affect the 
antiproliferative activity. Besides, if has been previously reported that the water-
soluble sclerotial polysaccharides (SCP) from PTR had a MW of 43.5 xlO"^  and was 
suggested to be glucan which showed less effective growth inhibition on HL-60 cells 
than other PTR extracts (Zhang et al, 2006a). 
Furthermore, HWEs isolated from PTR fruiting body consisted of mainly 
glucose, mannose and galactose, and strong UV absorbance was observed in HPLC, 
‘ speculating they are likely to be a heteropolysaccharide-protein complex. The HWE2 
‘ fraction seemed to be the most potent ones among the three HWEs having the 
highest carbohydrate content and lowest protein amount as well as a higher 
molecular weight, all of which might facilitate its cytotoxicity towards cancer cells. 
Its antiproliferation against HL-60 cells via apoptosis and S arrest might be 
associated with the downregulated Bcl-2 and Cdk2 levels and the upregulated cyclin 
E，consistent with a previous study on PSP, which is a polysaccharide-protein 
complex from Coriolus versicolor, that also caused the S phase arrest and apoptosis 
in HL-60 cells by an increase of the Bax/Bcl-2 ratio and elevation of cyclin E level 
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(Hui et al.’ 2005; Yang et al, 2005). 
In summary, the mannose-rich CEP with the smallest molecular weight 
induced apoptosis in HL-60 cells in vitro whereas the glucose-rich EDP with 
moderate molecular weight inhibited the HL-60 cells in vitro by G2/M arrest and 
apoptosis. HWE2, having the highest molecular weight, was the most potent extract 
among the three PTR HWEs. HWE2 had considerable amount of protein which 
might be heteropolysaccharide-protein complex that exerted its in vitro 
antiproliferative activity towards HL-60 cells via S arrest and apoptosis. 
4.2 Future works 
HWE2 had a stronger antiproliferative activity than HWEl and HWES, 
suggesting it might have potential bioactive components that had substantial growth 
inhibitory effect. Therefore, further analysis on the detailed structure of PTR extracts 
including their glycosidic linkages, degree of branching, molecular conformation in 
s6lution, the amount of bound protein and its moiety are required in order to explain 
i 
their different mode of actions towards the antiproliferation of cancer cells. Also, the 
V 
PTR extracts were quite heterogeneous and hence fractionation and deproteinization 
could be done and attempt to find out the bioactive components they contained and 
the association with their antiproliferative potency. It is anticipated that the 
understanding of such structure-activity relationship in mushroom polysaccharides 
can provide more insights on their applications in cancer treatment. 
Moreover, the detailed mechanistic pathway of the PTR-induced cytotoxicity 
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is not yet fully understood. The cellular molecules involving in the signal 
transduction pathways regulating the cell-cycle control and the two apoptotic 
pathways (extrinsic and the intrinsic ones) should be further analyzed in details. 
Besides, as the PTR extracts could generally inhibit the growth of HL-60 and 
K562 cells in vitro, they might be effective in treating these two types of cancer, In 
future, in vivo animal studies should be carried out to check whether the PTR extracts 
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